rfhg_81336.1

Basic information about the TSS

---

TSS ID: rfhg_81336.1 Species: human Chr: chr6		Start: 32976691 End: 32976705 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000481259.1:-122 GeneID: 6046 HGNC/MGI_ID: HGNC:1103 UniProt_ID: H0YDJ7 Nearer transcript ids and distances:

Gene_name: BRD2 Gene_symbol: BRD2 Gene_synonyms: D6S113E FSRG1 KIAA9001 NAT RING3 Gene_source: HGNC:1103

TATA-Box annotation

---

Distance to TSS:	3614
Nearest PromoterID:	NM_001199456
Entrez ID:	6046
Nearest Unigene:	Hs.75243
Nearest Refseq:	NM_005104
Nearest Ensembl:	ENSG00000204256
Gene Name:	BRD2
Gene Alias:	BRD2-IT1|D6S113E|FSH|FSRG1|NAT|O27.1.1|RING3|RNF3
Gene Type:	protein-coding
CpG%:	0.071429
GC%:	0.733333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@BRD2 p2@BRD2 p3@BRD2 p4@BRD2 p5@BRD2 p7@BRD2 p8@BRD2 p9@BRD2 p10@BRD2
Sample		p1@BRD2	p2@BRD2	p3@BRD2	p4@BRD2	p5@BRD2	p7@BRD2	p8@BRD2	p9@BRD2	p10@BRD2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	492.85	16.75	34.48	6.82	1.36	2.14	3.12	0.78	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	507.21	21.65	38.64	6.07	1.62	4.05	1.42	0.40	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	478.21	21.80	36.07	8.87	0.96	4.63	2.12	0.96	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	423.10	16.01	29.52	5.61	1.04	3.33	0.83	0.62	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	438.23	17.77	29.25	5.85	1.57	2.70	0.90	0.45	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	442.28	11.24	30.82	8.53	1.16	1.94	1.74	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	443.17	15.47	30.94	5.88	0.65	1.31	1.31	1.31	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	446.65	13.08	25.68	7.51	1.70	1.21	0.97	0.97	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	403.71	13.04	28.42	8.55	1.92	1.50	2.56	0.43	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	727.43	34.78	46.37	11.59	4.06	3.48	5.80	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	654.86	43.66	45.68	10.91	2.83	7.68	9.70	1.21	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	661.46	40.66	41.06	8.13	2.03	2.44	6.91	0.81	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	46.58	4.03	5.32	1.61	0.00	0.64	0.48	0.32	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	35.78	4.36	5.11	0.90	0.45	0.00	0.00	0.45	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	34.47	3.51	5.49	1.32	0.44	0.22	0.44	0.66	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	44.51	3.52	4.78	2.26	0.25	0.50	0.50	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	36.47	4.15	5.68	1.53	0.22	0.87	0.66	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	43.45	2.95	5.48	1.69	0.00	0.84	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	38.92	1.60	3.20	0.53	0.53	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	57.17	3.01	4.96	0.90	0.30	0.90	0.30	1.20	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	54.53	4.01	4.68	1.07	0.40	0.40	0.27	0.53	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	52.13	3.63	6.04	0.35	0.35	0.17	0.69	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	42.01	3.23	5.43	0.65	0.39	0.52	0.65	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	41.74	2.18	5.82	0.73	0.00	0.49	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	39.47	3.35	3.87	0.52	0.00	0.52	0.26	0.77	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	35.45	1.90	4.75	2.22	0.32	0.32	0.63	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	35.71	3.85	7.14	2.20	0.55	0.55	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	44.79	4.48	7.07	0.47	0.24	0.24	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	41.83	3.55	6.30	1.13	0.81	0.32	0.48	0.81	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	37.46	3.26	3.98	1.09	0.54	0.00	0.36	1.27	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	44.38	1.26	3.56	0.84	0.21	0.21	0.00	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	39.86	1.17	2.74	0.78	0.20	0.59	0.20	1.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	36.30	1.27	4.64	2.53	0.00	0.21	1.06	1.06	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	43.71	2.47	3.96	1.48	0.49	0.00	0.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	49.55	1.50	2.06	0.75	0.00	0.19	0.93	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	49.44	2.49	3.26	0.57	0.19	0.57	0.38	0.00	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	50.89	2.86	4.91	1.23	0.20	0.00	0.41	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	43.12	2.62	4.63	1.81	0.40	0.00	0.60	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	54.02	1.89	4.86	0.54	0.00	0.27	0.27	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	46.57	4.08	5.04	0.72	0.72	0.72	0.72	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	41.41	4.47	5.18	0.94	0.00	0.24	0.71	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	46.70	3.07	5.12	1.76	0.15	0.00	1.17	0.29	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	66.01	2.32	4.85	1.27	0.21	1.05	0.84	1.48	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	57.69	1.92	5.07	0.70	0.17	0.00	1.05	1.22	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	59.83	2.01	5.62	2.01	0.40	0.80	0.60	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	60.26	1.86	5.35	2.56	0.93	0.00	1.63	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	58.78	3.12	3.84	1.92	0.72	0.24	0.48	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	64.08	2.68	4.47	0.89	0.89	0.00	0.60	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	56.49	3.11	6.22	1.20	0.72	0.24	1.68	1.44	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	59.65	2.63	5.66	1.42	0.20	0.40	1.21	1.82	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	69.48	2.46	3.48	1.84	0.20	0.00	2.05	1.02	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	64.27	5.11	4.67	1.78	0.67	0.67	0.89	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	54.29	3.55	3.55	1.77	0.71	0.35	1.06	1.42	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	40.43	5.30	4.31	1.33	0.66	0.66	2.65	1.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	87.25	3.36	5.87	5.03	0.84	0.84	3.36	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	55.11	2.76	7.35	2.76	0.92	0.00	1.84	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	35.00	2.27	4.21	1.94	0.32	0.00	0.65	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	40.15	3.21	2.57	1.28	0.96	0.64	1.28	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	72.30	5.34	7.23	0.94	1.26	0.00	1.57	1.26	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	36.66	4.23	2.12	1.41	2.12	0.00	2.82	2.12	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.92	2.24	3.36	0.56	1.12	1.12	4.49	2.24	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	65.28	3.98	3.18	5.57	0.00	0.00	1.59	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	46.89	2.04	1.36	1.36	0.68	0.00	1.70	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	57.84	2.27	2.60	2.27	1.62	0.65	1.62	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	31.59	3.55	4.61	1.42	0.35	0.35	1.06	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	32.33	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	63.18	0.00	0.00	0.00	0.00	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	35.10	2.44	4.88	3.41	0.49	0.49	0.98	1.46	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	28.26	2.48	2.98	1.49	0.50	0.00	2.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	23.92	1.41	3.28	0.47	0.00	0.00	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	38.09	3.64	5.96	1.32	0.00	0.00	1.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	41.76	2.17	1.24	1.86	0.62	0.31	1.86	0.62	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	34.24	3.36	1.83	1.22	0.00	0.31	1.83	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	42.13	3.64	5.23	0.95	0.32	0.32	0.95	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	52.46	4.65	4.01	1.76	0.32	0.32	1.60	0.64	0.00
Adipocyte - omental, donor1	11473-119C6	54.07	3.69	6.11	2.16	0.38	0.38	1.65	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	30.65	2.99	5.98	1.49	0.00	0.00	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	37.85	6.36	3.01	0.67	0.33	0.33	2.01	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	28.07	3.19	7.66	0.64	0.00	0.00	2.55	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	39.58	4.40	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	34.32	2.26	3.61	0.45	0.00	0.00	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	49.00	7.47	2.78	1.04	0.52	0.17	1.22	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	52.61	9.97	6.06	0.98	0.78	0.39	1.17	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	32.69	7.46	5.40	0.77	1.29	0.77	2.57	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	37.36	8.36	5.85	0.28	1.67	0.84	3.90	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	33.51	7.05	7.64	0.59	2.35	0.00	1.18	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	52.84	9.65	5.79	0.40	0.48	0.72	0.88	0.64	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	36.15	7.10	3.87	0.65	0.32	1.29	2.26	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	35.72	6.40	8.00	1.07	0.00	0.00	3.73	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	34.50	7.23	7.23	0.00	0.56	0.00	2.23	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	49.49	6.65	6.65	0.42	0.00	0.42	2.91	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	29.89	5.27	7.53	0.50	1.76	1.00	2.51	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	40.91	5.24	6.87	0.33	0.33	0.65	0.33	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	32.88	6.09	4.26	0.30	0.00	0.00	0.61	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	49.50	5.30	4.42	0.00	0.22	0.00	0.44	0.22	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	43.39	8.25	6.10	0.36	1.08	1.08	1.08	1.79	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	32.35	3.59	4.79	0.00	3.59	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	54.51	9.53	8.82	0.90	0.36	0.90	0.18	0.90	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	38.49	23.43	5.02	1.67	1.67	1.67	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	69.44	9.25	10.68	0.41	0.82	0.41	1.03	1.23	0.00
Anulus Pulposus Cell, donor1	11248-116E6	34.90	8.24	4.81	0.57	0.92	0.46	0.23	0.34	0.69
Anulus Pulposus Cell, donor2	11463-119B5	34.53	8.82	2.69	0.00	0.24	0.49	0.24	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	41.34	2.25	7.64	0.90	0.45	0.45	1.35	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	35.60	1.74	3.91	1.74	0.43	0.00	0.43	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	4.28	6.42	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	38.26	3.29	4.78	0.60	0.60	0.90	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	43.00	2.53	2.53	1.26	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	25.08	2.64	4.62	0.66	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	32.81	3.90	3.57	0.32	0.32	0.00	1.95	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	43.20	3.40	4.37	1.46	0.97	0.00	1.46	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	30.88	4.75	1.78	1.78	0.00	0.00	0.00	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	40.68	4.14	4.14	1.51	0.75	0.00	0.75	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	32.66	3.63	0.73	0.73	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	2.51	2.51	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.18	2.47	3.95	0.33	0.33	0.66	0.82	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	42.31	6.82	0.00	0.00	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.79	2.87	2.26	0.15	0.30	0.30	1.36	0.15	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	43.93	2.68	4.29	1.07	0.00	0.00	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	37.41	5.29	1.51	0.57	0.38	0.00	1.70	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	44.64	3.47	1.07	1.34	0.00	0.27	1.07	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	39.02	5.85	6.83	0.00	0.00	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	32.84	2.65	3.48	0.66	0.33	0.50	0.83	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	3.60	3.60	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	56.64	7.08	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	38.08	3.26	4.12	1.37	0.00	0.34	1.03	0.86	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	8.39	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	36.89	5.83	4.37	0.49	0.49	0.00	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	39.84	4.17	3.79	0.38	0.38	0.00	0.38	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	31.50	0.00	0.00	3.63	0.00	0.00	2.42	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	27.93	6.27	3.99	0.00	0.00	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	36.56	3.63	4.70	0.86	0.43	0.21	0.86	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	30.97	3.61	3.87	0.77	0.26	0.26	0.52	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	34.25	1.88	2.82	0.94	0.94	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	29.90	1.93	5.14	0.64	0.00	0.32	0.64	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.82	4.99	1.43	0.00	0.71	0.00	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	28.08	3.51	2.34	0.58	0.00	0.58	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	35.53	2.11	3.31	0.60	0.30	0.00	0.30	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	3.56	1.19	0.00	0.00	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.99	6.61	5.59	1.53	0.51	0.51	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	35.15	2.55	1.78	1.27	0.25	0.76	1.02	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.97	3.18	1.91	0.64	0.00	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	32.80	3.88	3.45	0.43	0.43	0.43	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	33.66	3.18	1.69	0.21	0.21	0.00	0.42	0.21	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	29.58	1.45	3.48	0.29	0.58	0.00	0.87	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	33.07	3.78	3.78	0.00	0.00	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	34.75	3.56	2.37	0.17	0.34	0.68	0.68	0.00	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	2.32	0.00	0.00	2.32	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	65.49	4.23	4.23	0.00	0.00	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	40.31	4.93	3.65	0.43	0.43	0.00	0.86	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	36.10	3.01	3.01	0.60	0.00	0.60	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	45.20	3.64	2.92	0.00	0.00	0.73	0.73	0.00	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	42.30	3.91	5.29	0.00	0.46	0.00	1.38	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	45.91	2.55	5.10	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	19.58	4.07	2.03	0.51	0.51	0.00	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	46.04	3.92	3.30	0.41	0.00	0.41	2.06	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	33.97	2.75	9.18	1.53	0.00	0.00	0.00	0.31	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	42.54	2.87	5.26	0.96	0.00	0.00	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	40.80	2.88	4.21	1.33	0.22	0.22	1.33	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	6.10	3.05	0.00	0.00	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	34.34	2.77	3.88	0.55	0.55	0.00	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.10	3.18	4.50	0.79	0.00	0.00	1.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.17	4.36	3.27	0.00	0.73	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	77.87	10.44	10.07	0.74	0.74	0.74	0.86	1.35	0.74
Astrocyte - cerebellum, donor2	11580-120F5	65.73	6.50	6.50	0.34	1.20	0.34	0.68	1.03	0.68
Astrocyte - cerebellum, donor3	11661-122F5	59.36	11.75	6.92	0.84	1.89	0.00	0.84	0.84	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	43.57	16.03	9.76	0.35	0.70	0.35	0.70	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	60.50	9.38	5.66	0.81	1.13	1.13	1.13	0.81	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	50.27	9.84	6.56	1.49	0.75	0.75	1.19	0.45	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	132.58	7.11	20.99	3.21	1.49	0.92	1.72	2.18	2.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	158.86	7.89	18.17	3.26	1.75	0.88	1.63	3.13	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	137.12	8.19	19.23	2.16	3.53	0.80	0.46	1.82	1.37
Basophils, donor1	12241-129G9	95.20	39.75	7.32	0.52	1.31	1.57	1.05	0.26	0.52
Basophils, donor2	12242-129H1	132.41	39.33	14.43	0.36	1.44	2.16	1.44	1.44	0.00
Basophils, donor3	12243-129H2	70.41	30.13	9.41	0.29	2.06	2.20	1.62	0.73	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	40.10	8.19	5.82	0.43	0.22	1.29	0.43	0.22	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	40.23	6.40	8.23	0.46	0.00	0.00	0.46	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	14.35	7.17	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	55.23	6.28	3.77	0.63	0.00	0.00	1.88	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	46.58	4.57	3.33	0.00	0.42	0.42	0.42	0.21	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	55.50	8.75	6.22	0.92	1.15	0.23	1.15	0.00	1.84
Bronchial Epithelial Cell, donor7	11769-123I5	46.79	4.68	2.16	1.26	0.00	0.72	0.18	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	126.14	12.06	15.56	0.93	2.58	2.37	0.41	2.37	1.13
Burkitt's lymphoma cell line:RAJI	10476-106I8	95.02	8.85	16.30	2.33	2.10	1.40	0.47	1.63	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	39.33	15.99	12.15	0.00	3.84	1.60	0.96	1.60	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	10.34	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	36.63	28.74	6.76	0.00	2.25	2.82	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	101.15	24.87	7.05	2.60	2.04	1.86	0.56	0.56	0.37
CD14+ Monocytes, donor3	11381-118B4	78.15	19.32	10.98	1.54	1.10	3.73	0.66	0.88	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	37.36	29.15	17.27	0.85	1.70	4.25	0.00	0.57	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	31.84	23.50	7.96	0.76	0.38	4.55	0.00	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	39.78	22.03	10.52	0.99	0.33	2.96	0.99	0.99	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	143.54	45.24	12.14	4.05	3.32	4.48	1.30	1.45	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	115.27	30.48	11.47	3.92	3.02	5.13	1.21	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	171.75	42.64	12.32	2.37	2.13	3.32	1.42	2.13	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	174.43	31.97	8.04	4.18	1.51	2.34	2.01	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	168.92	21.80	9.94	2.21	1.38	1.38	2.21	0.83	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	179.25	23.31	4.96	1.24	0.99	2.23	0.99	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	173.09	15.66	4.90	3.92	1.37	1.37	1.96	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	167.37	20.12	5.16	3.92	1.25	1.96	0.36	0.89	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	140.59	18.50	7.40	0.65	0.65	2.61	1.96	0.44	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	156.86	10.30	5.38	2.34	0.94	1.40	0.94	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	184.28	7.39	10.03	3.17	1.06	0.00	2.64	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	262.92	21.08	7.77	3.33	2.22	1.11	2.22	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	142.50	29.30	8.78	5.06	2.53	2.38	3.42	0.89	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	142.68	23.75	8.38	3.19	1.20	3.59	1.20	0.80	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	125.96	25.19	8.74	1.25	0.83	2.08	1.87	0.62	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	153.97	13.04	4.35	2.97	0.46	1.37	1.14	0.92	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	108.58	13.12	4.98	2.49	0.90	1.58	0.00	0.90	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	173.71	17.02	3.93	2.62	1.31	1.31	1.31	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	168.93	36.85	10.22	3.77	2.69	3.23	2.96	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	169.05	31.05	7.68	1.74	1.40	3.49	1.05	0.52	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	167.91	46.29	10.52	4.63	1.68	3.79	2.52	1.68	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	141.82	14.33	5.33	2.94	1.29	1.84	2.57	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	189.52	14.09	4.23	1.76	1.06	1.41	0.70	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	211.90	11.41	7.46	2.63	0.00	3.07	3.07	1.75	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	174.72	26.68	5.23	4.53	0.87	1.92	1.39	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	175.43	18.21	7.06	2.97	1.49	1.49	1.12	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	155.20	26.51	8.41	1.94	1.08	3.23	1.08	1.51	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	185.09	18.84	6.55	3.69	0.41	2.05	3.28	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	131.66	8.34	7.42	2.78	0.70	2.78	1.39	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	168.66	12.99	4.87	2.09	0.23	2.09	1.62	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	29.43	32.04	7.41	0.65	2.40	1.74	1.09	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	35.57	52.67	9.47	0.00	2.31	3.93	2.31	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	25.99	29.89	6.72	0.22	3.47	1.30	0.22	0.65	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	41.89	57.31	13.70	0.47	2.65	2.65	0.93	0.31	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	37.02	65.84	13.27	0.70	4.72	3.84	1.22	1.05	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	42.14	50.61	10.03	2.01	4.24	4.01	0.89	0.89	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	29.09	35.72	5.87	0.00	1.79	3.57	2.04	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	29.42	37.98	11.20	0.22	2.20	0.66	1.32	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	28.63	32.63	9.26	0.00	1.47	1.89	1.47	0.63	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	36.58	42.68	32.52	0.00	4.06	10.16	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	54.24	33.90	29.15	0.00	2.03	6.10	0.68	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	52.82	38.32	41.42	2.07	8.28	7.25	0.00	1.04	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	205.75	68.76	35.18	0.00	11.19	5.33	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	50.39	57.90	40.74	1.07	4.82	6.97	0.54	2.68	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	52.65	51.24	31.59	1.40	1.40	5.62	1.40	0.70	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	51.77	50.20	36.08	0.00	1.57	5.49	0.78	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	48.78	43.50	39.55	2.64	3.95	7.91	0.00	2.64	1.32
CD19+ B Cells, donor1	11544-120B5	207.12	21.37	18.90	5.75	16.44	1.64	0.00	4.93	1.64
CD19+ B Cells, donor2	11624-122B4	151.61	13.06	15.23	1.45	7.98	0.73	2.18	1.45	1.45
CD19+ B Cells, donor3	11705-123B4	145.39	18.17	19.69	4.04	10.10	3.03	2.02	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	87.68	9.29	32.32	2.83	1.62	1.21	0.81	0.40	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	57.13	9.99	23.57	0.00	2.40	1.60	0.80	0.80	0.40
CD34+ Progenitors, donor1	11545-120B6	44.18	6.02	6.02	0.00	3.01	0.00	1.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	82.59	12.92	8.99	0.56	1.69	2.81	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	44.34	10.15	13.53	2.63	1.88	2.63	0.75	1.13	3.01
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	44.42	9.92	9.24	0.90	3.61	2.48	0.68	1.13	4.51
CD4+ T Cells, donor1	11225-116C1	170.32	9.28	21.42	3.21	2.50	1.43	0.00	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	259.03	9.80	14.08	5.51	4.90	3.67	0.00	3.67	0.61
CD4+ T Cells, donor3	11382-118B5	182.69	5.79	15.86	3.35	2.44	1.83	0.30	3.05	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	58.70	35.22	23.74	0.51	6.89	6.13	0.77	1.53	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	66.03	28.30	24.48	2.70	5.39	5.84	0.22	2.25	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	60.65	38.52	26.73	2.59	5.75	4.89	1.15	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	60.68	16.12	31.29	0.95	3.79	1.90	0.00	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	54.08	15.45	25.99	0.00	3.51	3.51	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	92.29	19.78	23.07	0.00	13.18	3.30	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	57.81	23.56	14.31	1.01	3.76	4.05	0.58	2.46	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	68.97	20.50	16.27	1.69	4.58	4.74	0.51	2.03	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	64.00	23.05	19.51	1.77	4.67	4.19	0.00	2.58	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	86.07	17.48	12.55	0.45	2.69	2.69	0.45	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	53.81	27.95	17.47	0.35	5.24	3.49	0.00	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	79.20	18.48	18.04	3.08	5.28	2.64	0.00	2.64	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	57.34	32.04	16.44	0.84	5.48	4.64	1.69	1.69	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	70.02	24.52	14.96	2.08	3.74	3.95	0.62	2.91	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	55.47	24.39	13.37	2.00	4.34	3.01	0.33	2.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	63.36	17.13	23.66	2.18	5.71	4.62	0.27	1.09	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	37.52	20.37	32.69	0.00	6.97	4.82	0.54	0.54	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	69.94	8.97	23.31	3.59	10.76	5.38	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	64.90	27.44	18.54	1.67	5.75	5.38	0.74	2.23	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	61.30	21.23	21.66	1.73	5.85	4.33	0.43	2.60	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	63.47	32.36	14.29	1.05	4.20	8.20	1.05	3.78	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	85.95	15.67	10.11	1.01	2.02	6.07	0.00	1.52	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	47.66	16.03	16.46	0.43	0.87	5.20	0.00	0.87	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	70.60	12.64	17.87	1.31	6.54	3.05	0.00	1.74	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	48.99	41.07	35.63	0.49	2.47	7.92	1.48	0.49	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	33.23	35.08	41.54	0.00	1.85	7.39	1.85	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	44.67	23.73	1.40	2.79	5.58	1.40	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	78.92	40.43	43.48	1.38	7.48	9.97	0.00	3.88	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	66.01	44.42	47.12	0.74	4.42	10.06	0.74	2.94	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	58.52	41.58	46.20	0.00	4.62	4.62	0.00	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	59.81	45.48	39.39	1.43	3.58	7.52	0.36	2.51	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	63.71	33.24	44.32	0.00	1.38	8.31	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	197.09	10.80	16.37	2.29	0.33	3.93	0.33	0.33	0.65
CD8+ T Cells, donor2	11307-117C2	285.33	13.14	12.76	5.26	1.88	1.88	1.88	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	248.45	8.84	17.42	5.55	1.77	2.27	0.00	2.78	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	78.91	5.28	16.06	1.38	3.21	0.46	5.51	0.23	2.98
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	81.96	7.91	12.70	1.44	3.59	0.48	3.59	1.20	2.88
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	81.53	4.65	16.42	1.92	4.38	0.55	5.75	0.55	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	120.68	3.60	14.71	0.90	3.30	1.20	5.10	0.90	3.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	82.07	3.84	17.04	0.96	2.64	0.48	2.64	0.48	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	90.50	5.46	12.73	0.91	2.73	1.14	4.78	1.36	2.05
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	79.53	5.00	13.25	1.09	2.17	0.43	4.56	0.87	2.17
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	84.49	4.21	13.16	1.05	1.32	0.53	2.90	0.00	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	87.24	4.22	15.24	1.64	1.17	0.23	3.52	0.47	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	84.53	3.32	15.70	1.21	0.91	0.60	3.92	0.60	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	81.05	4.94	12.20	1.45	1.16	0.58	2.03	1.16	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	91.92	3.73	10.92	0.80	1.07	0.80	1.07	0.80	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	196.11	4.82	13.57	3.06	1.31	3.06	9.19	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	204.49	4.55	8.20	0.91	0.91	0.46	3.19	0.91	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	187.21	5.97	7.46	4.48	0.00	0.75	8.95	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	104.45	4.68	18.01	1.44	2.88	1.44	6.48	0.00	2.52
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	88.04	5.18	16.98	0.86	2.01	0.58	4.32	0.58	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	86.03	5.42	13.43	1.41	2.83	1.41	5.66	1.18	2.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	105.21	4.75	16.80	0.95	0.95	0.63	3.49	2.22	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	97.81	5.54	10.46	1.54	1.54	0.62	2.15	1.85	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	72.13	3.21	14.11	1.28	0.96	1.60	3.53	0.96	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	86.82	11.09	12.62	0.76	1.53	0.38	3.44	1.15	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	83.94	7.09	12.61	0.39	2.36	0.79	5.12	1.58	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	88.50	4.54	13.62	3.03	2.27	1.51	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	350.89	15.26	28.10	3.21	0.80	0.80	21.68	0.80	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	413.36	18.19	25.88	6.29	4.20	1.40	16.79	2.80	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	403.71	10.02	21.04	2.00	8.01	2.00	17.03	5.01	2.00
Cardiac Myocyte, donor1	11525-119I4	42.04	7.31	5.48	5.48	0.00	1.83	5.48	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	37.55	2.96	4.94	0.00	0.00	0.49	2.47	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	27.68	2.10	1.37	0.11	0.11	0.00	0.84	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	27.39	6.59	4.85	0.35	0.00	0.69	0.69	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	32.69	5.33	6.40	0.36	0.36	0.36	1.42	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	36.98	5.46	8.76	0.68	0.23	0.23	1.59	0.57	0.34
Chondrocyte - re diff, donor2	11339-117F7	34.02	4.48	2.69	0.90	0.00	0.00	4.48	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	80.48	14.15	14.15	0.81	1.62	0.81	3.24	0.40	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	47.85	9.41	6.66	1.03	0.80	0.69	0.92	0.23	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	54.72	3.85	3.42	1.28	0.00	0.43	0.86	0.00	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	48.76	5.58	7.17	1.15	0.71	0.62	0.88	0.53	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	64.83	18.34	17.51	1.93	1.83	2.02	1.93	4.59	1.10
Corneal Epithelial Cells, donor1	11526-119I5	47.87	6.37	5.93	0.66	0.00	0.44	0.88	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	38.68	13.65	12.51	1.14	0.00	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	47.80	7.92	4.35	0.77	1.28	1.53	0.51	0.51	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	27.57	13.37	4.79	0.50	0.00	1.16	0.17	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	25.86	14.51	5.36	0.95	0.32	0.95	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	17.25	10.35	0.00	3.45	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	33.04	10.69	6.91	0.54	0.22	0.54	0.54	0.65	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	111.38	15.03	31.43	1.02	3.76	5.12	1.37	0.68	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	114.25	7.83	16.97	0.65	5.88	1.96	1.31	1.31	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	72.11	13.07	23.23	0.48	4.84	2.90	1.94	1.45	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	30.35	2.50	3.67	0.17	0.17	0.67	0.33	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	34.03	4.11	0.59	0.00	0.59	0.00	1.76	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	32.24	3.68	3.68	0.00	0.28	0.00	0.28	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	31.06	2.75	0.79	0.00	0.00	0.00	1.18	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	34.90	2.62	2.62	0.29	0.58	0.00	0.29	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	56.00	3.29	3.53	0.71	0.24	0.47	0.94	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	46.28	3.33	2.63	1.23	0.35	0.18	1.23	1.05	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	24.16	4.43	4.65	0.66	0.44	0.22	0.89	0.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	28.60	2.43	1.83	0.61	0.61	0.00	1.22	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	33.26	5.36	4.51	0.85	0.85	0.28	1.41	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	35.66	5.35	7.73	0.89	0.00	0.00	0.89	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	30.20	3.64	2.08	0.52	0.00	1.56	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	31.48	3.83	5.53	0.43	0.57	0.14	0.43	0.85	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	54.02	6.80	4.80	0.40	0.80	0.00	0.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	36.69	4.72	1.05	1.05	0.00	0.52	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	47.46	6.46	5.22	0.75	0.75	1.86	0.87	0.75	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	37.15	8.26	3.48	0.43	0.87	0.43	0.43	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	40.55	5.37	4.40	0.49	0.37	0.37	0.37	1.10	0.37
Endothelial Cells - Vein, donor1	11267-116G7	70.53	2.28	5.69	0.00	0.00	0.00	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	42.61	3.49	4.19	0.00	0.70	0.00	0.70	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	39.41	2.98	4.08	0.47	0.31	0.47	0.94	0.31	0.16
Eosinophils, donor1	12244-129H3	30.49	15.25	15.25	0.00	0.00	15.25	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	462.07	107.27	3.30	1.65	3.30	8.25	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	431.59	89.17	7.13	3.57	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	39.34	5.86	5.38	0.73	0.24	0.00	0.49	0.98	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	43.68	2.08	4.16	0.00	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	32.84	1.64	2.87	0.41	0.41	1.23	0.41	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	21.90	1.09	0.88	1.42	0.11	0.11	0.33	0.22	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	24.59	3.68	2.28	1.73	0.00	0.54	0.65	0.43	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	31.17	3.76	5.34	1.58	0.36	0.61	3.03	0.12	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	58.41	15.01	8.46	0.55	0.55	0.96	7.37	0.00	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	39.02	2.32	2.74	1.48	0.00	0.11	1.48	0.21	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	45.58	12.65	11.33	0.53	1.84	0.53	6.06	0.26	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	31.89	4.32	5.32	2.66	0.33	0.00	1.00	0.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	40.37	2.72	3.18	0.45	0.45	0.45	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	46.99	4.55	1.52	0.00	0.00	0.76	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	38.96	2.68	3.47	0.79	0.16	0.79	1.42	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	40.62	9.09	6.37	0.00	0.30	0.61	2.12	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	34.14	6.60	5.58	0.38	0.89	0.25	2.03	0.63	1.14
Fibroblast - Cardiac, donor6	11460-119B2	31.53	4.55	4.09	0.76	0.15	0.61	2.43	0.45	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	65.39	9.11	8.71	0.54	0.80	1.07	2.41	0.67	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	37.10	6.47	5.18	0.86	0.43	0.43	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	52.73	2.93	4.39	1.46	0.00	0.00	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	133.54	14.99	10.84	0.69	2.31	0.92	4.61	0.46	1.61
Fibroblast - Conjunctival, donor3	11692-122I9	44.61	8.82	12.04	0.68	0.34	0.51	1.53	1.19	0.34
Fibroblast - Dermal, donor1	11269-116G9	40.85	2.11	3.05	0.70	0.23	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	47.64	1.89	1.89	0.47	0.47	0.00	1.42	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	38.20	3.38	3.51	0.48	0.12	0.48	1.21	0.48	0.00
Fibroblast - Dermal, donor4	11450-119A1	55.73	8.37	5.20	1.47	1.02	0.57	2.15	0.90	1.36
Fibroblast - Dermal, donor5	11454-119A5	53.56	5.76	6.11	1.57	0.52	0.70	2.09	1.05	0.70
Fibroblast - Dermal, donor6	11458-119A9	58.63	5.20	4.55	0.49	0.81	0.49	0.81	0.65	0.32
Fibroblast - Gingival, donor1	11237-116D4	31.65	6.25	4.58	0.62	0.00	0.62	1.04	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	68.64	7.60	6.03	1.31	0.26	0.26	1.57	0.79	0.79
Fibroblast - Gingival, donor2	11318-117D4	51.66	5.67	5.27	1.84	0.53	0.26	0.92	0.53	0.40
Fibroblast - Gingival, donor3	11394-118C8	64.20	11.41	6.38	1.06	0.77	1.26	0.39	0.58	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	32.21	7.27	6.23	0.00	1.04	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	37.71	8.11	3.70	1.06	0.70	0.18	1.41	0.88	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	59.24	6.24	5.46	1.25	0.16	0.62	2.34	0.16	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	48.14	5.41	4.73	1.22	0.41	0.00	1.49	0.54	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	109.75	10.94	9.88	0.35	0.35	1.41	3.88	0.35	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	47.24	7.60	5.26	0.58	0.15	0.44	1.02	0.00	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	62.45	6.00	5.59	0.95	0.27	0.41	1.77	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	82.05	4.50	5.27	0.88	0.33	0.33	2.41	0.22	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	73.22	17.46	11.15	1.91	1.47	1.17	1.17	0.59	0.59
Fibroblast - Lung, donor1	11270-116H1	53.01	1.36	5.44	0.00	1.36	1.36	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	65.65	10.45	8.95	1.49	1.49	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	52.97	6.33	5.70	0.42	0.21	0.00	0.63	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	120.79	9.16	6.66	1.67	0.83	0.00	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	29.37	2.80	2.80	0.00	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	52.62	4.76	3.36	0.28	0.28	0.56	0.56	0.00	0.84
Fibroblast - Mammary, donor1	11540-120B1	143.31	7.31	8.53	0.41	0.41	0.41	0.41	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	71.90	0.00	0.00	0.00	3.99	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	59.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	40.35	7.76	7.18	0.97	0.39	0.78	0.97	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	64.46	6.98	5.61	1.82	0.15	0.30	0.46	0.61	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	65.18	4.59	3.37	0.61	0.00	0.31	0.61	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	41.98	5.72	1.53	0.38	0.38	1.53	4.20	0.00	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	39.42	5.40	5.40	1.08	0.27	0.00	0.81	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.95	7.42	3.83	0.58	0.35	0.70	1.04	0.58	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	25.75	1.66	1.55	0.11	0.11	0.00	0.66	0.22	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	116.83	4.88	6.91	0.61	0.20	0.20	2.24	0.41	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	49.45	6.68	8.69	0.67	0.00	0.67	1.34	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	39.54	3.95	3.16	0.40	0.00	0.40	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	121.85	17.26	18.46	2.38	2.18	0.79	8.33	0.20	2.38
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	41.21	8.88	7.28	0.53	0.36	0.18	1.78	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	38.83	7.69	6.31	0.59	0.39	0.39	2.56	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	77.02	12.94	9.03	1.20	0.90	1.50	6.32	0.00	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	49.33	5.72	7.12	0.22	0.11	0.11	1.94	0.43	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	85.03	21.26	11.89	2.28	1.01	1.77	4.30	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	39.87	8.53	5.58	0.66	0.00	0.16	0.16	0.49	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	84.21	16.04	12.83	1.60	1.80	0.60	8.02	0.00	1.60
Fibroblast - skin normal, donor2	11561-120D4	48.22	10.05	6.33	0.90	0.70	0.50	2.11	0.60	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	103.37	15.11	12.39	2.12	0.91	1.81	6.95	0.60	3.02
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	45.73	8.12	7.12	0.91	0.25	0.33	1.41	0.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	47.52	11.11	9.57	0.85	1.03	0.51	2.56	0.17	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	91.30	9.52	7.88	1.64	1.31	2.30	1.64	0.00	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	53.69	7.35	6.18	0.85	0.32	0.43	1.92	0.11	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	51.95	6.58	8.77	0.84	0.17	0.51	2.36	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	44.07	3.29	3.45	1.73	0.16	0.31	0.63	1.10	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	16.56	11.33	0.87	3.49	1.74	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	42.13	5.37	5.03	0.52	0.00	0.52	0.35	0.52	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	50.75	2.86	3.90	1.04	0.00	0.00	0.78	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	54.17	2.30	2.04	0.51	0.00	0.26	0.26	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	32.15	10.72	11.48	0.77	0.00	4.59	0.00	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	54.24	17.23	15.95	1.28	1.91	0.00	0.00	0.00	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	112.96	11.41	14.55	2.85	0.57	2.28	2.28	0.57	5.13
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	115.54	23.44	24.82	3.31	1.93	3.31	0.00	1.38	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	213.49	15.75	14.16	3.42	0.68	2.74	1.14	1.14	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	76.48	11.89	12.09	2.18	0.40	0.99	0.79	0.99	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	108.38	17.18	24.85	2.38	1.59	2.38	0.79	0.79	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	206.12	19.24	15.98	3.59	1.96	2.61	2.28	1.63	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	63.24	13.71	14.59	0.44	0.00	3.54	0.44	0.00	5.31
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	58.79	8.20	12.01	1.41	0.71	1.55	0.57	0.14	3.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	66.25	8.13	9.97	1.60	0.86	1.60	0.62	0.25	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	55.87	5.64	10.48	1.88	0.00	0.27	0.27	0.00	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	69.26	8.05	8.92	0.87	0.99	1.73	0.37	0.25	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	55.92	5.54	7.48	2.08	1.52	0.69	0.14	0.28	1.94
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	51.23	4.88	7.52	2.44	0.61	0.81	0.41	0.41	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	59.10	9.13	5.02	1.37	0.91	1.60	0.00	1.14	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	56.30	7.47	7.10	1.49	1.12	1.00	0.25	0.37	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	55.08	8.09	4.81	0.66	0.66	0.87	0.44	0.44	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	54.07	8.27	11.52	0.89	0.89	1.18	0.59	1.18	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	57.70	8.58	11.76	2.54	1.27	0.79	0.32	0.48	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	51.39	9.61	6.03	1.34	0.67	0.89	0.00	0.67	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	65.33	11.90	12.70	2.42	1.21	0.81	0.60	0.60	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	62.09	7.12	9.84	0.68	1.19	1.02	0.00	0.68	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	60.47	11.17	7.63	0.71	0.53	1.06	0.18	0.89	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	68.99	13.74	11.76	0.73	1.04	1.04	0.52	1.87	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	69.51	14.69	9.39	0.34	1.02	1.54	0.34	0.51	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	55.66	8.74	9.41	1.88	1.11	0.66	0.33	0.33	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	51.08	12.56	11.23	1.33	0.92	1.58	0.42	0.42	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	63.30	13.48	14.09	1.23	0.41	0.82	0.20	1.23	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	64.78	12.58	9.49	1.44	0.83	1.03	0.21	1.24	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	61.68	10.26	11.53	1.27	0.69	1.61	0.23	0.58	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	60.87	10.34	11.01	1.33	1.00	1.00	0.33	0.83	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	53.34	14.11	11.24	1.32	0.44	0.66	0.22	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	71.83	11.44	10.70	1.35	1.35	1.11	0.61	0.37	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	59.16	7.78	8.75	0.65	0.97	0.81	0.32	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	63.18	13.47	13.47	2.25	0.32	1.60	1.28	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	48.51	10.52	9.38	1.42	1.14	0.85	0.19	0.57	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	47.77	8.86	10.76	1.27	0.47	0.47	0.00	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	55.65	12.77	11.25	1.22	0.61	0.61	0.30	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	52.16	8.36	8.99	0.94	0.52	1.05	0.31	0.31	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	53.57	11.42	7.25	1.76	1.32	1.10	0.00	1.76	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	54.99	7.01	8.98	1.40	0.84	1.68	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.85	7.87	5.93	0.19	0.37	0.46	0.28	0.46	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	52.41	8.29	8.02	1.60	0.00	0.53	0.27	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	64.87	6.12	5.36	0.77	0.31	0.61	0.61	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	55.96	5.83	6.87	1.30	0.91	0.13	0.39	0.65	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	53.13	7.32	6.23	1.36	0.27	1.63	0.00	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	53.46	9.59	7.01	1.47	0.37	1.11	0.18	0.74	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	53.73	9.21	5.26	1.10	0.44	0.44	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	92.23	3.97	5.95	0.00	2.98	0.99	0.00	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	64.51	6.73	6.60	0.53	0.13	0.66	0.79	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	53.06	6.66	8.07	0.61	0.61	0.40	1.21	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	121.74	9.66	5.59	2.29	3.30	2.03	0.25	3.05	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	54.34	12.14	13.54	2.79	0.40	1.39	0.40	0.20	4.78
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	77.04	5.08	11.71	1.39	0.46	2.31	0.31	0.15	3.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	71.40	8.39	18.82	1.02	0.41	1.23	0.61	0.00	4.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	36.61	8.45	12.52	0.63	0.31	2.82	0.94	0.31	4.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	28.54	5.37	9.61	0.85	0.00	1.70	0.00	0.28	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	57.19	3.69	13.37	1.38	2.31	0.46	0.00	0.00	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	96.52	9.90	17.32	2.47	0.00	2.47	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	65.76	6.58	12.38	0.39	0.00	1.93	0.00	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	65.78	9.63	14.44	3.21	3.21	4.81	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	66.08	5.22	8.69	1.74	1.74	1.74	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	55.01	7.81	11.07	1.30	0.65	0.33	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	68.77	10.71	11.53	3.29	2.06	2.88	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	63.31	0.00	13.33	3.33	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	54.25	5.59	8.95	1.12	0.28	0.56	0.00	0.28	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	48.70	8.50	9.15	0.98	1.31	1.63	0.00	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	41.94	7.55	10.90	4.19	0.84	0.84	0.00	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	47.71	8.27	12.40	0.95	2.54	0.95	0.32	0.95	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	47.89	6.45	7.13	0.68	0.34	1.02	0.34	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	48.03	8.35	6.26	0.00	6.26	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	56.70	8.59	20.04	1.15	1.15	0.57	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	45.88	6.22	7.40	2.07	1.18	1.18	0.00	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	40.66	8.47	18.64	1.69	1.69	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	60.06	9.94	12.01	2.49	0.41	1.24	0.00	0.41	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	48.79	8.74	10.36	1.84	1.84	2.07	0.23	0.00	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	15.81	5.27	0.00	0.00	5.27	0.00	0.00	15.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	42.29	9.23	15.76	1.54	1.92	0.38	0.77	0.38	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	32.60	8.15	5.54	1.96	0.65	0.65	0.65	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	38.79	5.35	4.68	3.34	0.67	1.34	0.00	0.00	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	53.94	9.63	13.48	2.70	1.16	0.39	0.00	0.39	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	74.29	14.38	15.41	3.77	2.05	1.71	1.71	0.00	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	67.09	7.45	4.97	0.00	2.48	9.94	0.00	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	44.83	11.32	9.44	2.36	0.94	1.42	0.47	0.94	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	39.83	12.67	11.47	3.62	3.02	1.21	0.00	0.60	4.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	47.82	10.17	7.63	1.02	1.02	0.00	1.02	0.51	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	43.47	11.17	11.57	1.99	0.40	0.40	0.00	0.00	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	50.82	13.32	8.39	2.96	2.47	1.48	0.00	0.49	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	103.88	15.35	10.62	0.00	0.00	0.00	2.36	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	34.42	11.09	7.00	2.33	1.75	0.58	0.00	0.58	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	51.79	10.97	9.22	2.19	2.19	1.76	0.44	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	71.21	17.80	16.95	5.09	1.70	3.39	0.85	0.85	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	40.59	13.73	8.36	2.98	1.79	2.98	1.19	0.60	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	64.54	7.28	8.25	1.94	0.49	1.94	0.97	1.94	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	69.62	3.42	4.57	0.00	0.00	0.00	3.42	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	64.45	11.64	7.07	0.83	0.42	0.00	0.42	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	70.84	12.37	10.12	0.00	0.00	0.00	3.37	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	50.75	4.44	5.39	0.00	0.00	0.00	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	30.91	4.18	0.84	0.42	0.00	0.42	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	50.48	3.37	7.89	1.39	0.23	0.35	0.46	0.35	1.39
Hep-2 cells mock treated, biol_rep2	11899-125E9	61.11	5.23	9.62	1.01	0.51	0.84	0.51	1.18	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	56.42	4.55	8.65	1.59	0.46	0.23	0.46	0.00	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	55.97	3.72	7.98	1.64	0.66	0.55	0.22	0.55	1.31
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	56.95	3.01	9.03	1.07	0.64	0.64	0.21	0.43	2.36
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	68.24	3.01	7.97	1.51	0.22	0.65	0.65	0.22	1.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	47.82	4.11	3.74	0.62	0.50	0.37	0.62	0.25	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	52.32	3.77	3.77	0.69	0.69	0.69	0.51	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	52.86	2.88	7.69	1.92	0.00	0.32	1.60	0.64	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	47.57	5.60	3.92	1.12	1.12	1.12	0.00	1.68	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	67.08	2.60	0.43	0.43	0.43	0.00	1.73	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	2.64	10.58	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	63.49	7.41	6.70	0.00	0.00	1.06	2.82	0.71	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	59.57	2.91	6.54	0.73	0.00	0.00	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	39.51	1.05	2.80	0.70	0.17	0.17	1.22	0.17	0.35
Hepatocyte, donor1	11523-119I2	46.00	8.47	10.90	1.21	1.21	1.21	1.21	0.00	1.21
Hepatocyte, donor2	11603-120I1	56.02	19.39	18.31	2.15	1.08	4.31	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	50.92	6.75	6.75	1.23	0.61	1.23	1.84	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	255.20	3.26	20.23	5.87	8.48	1.96	0.00	1.31	13.05
Intestinal epithelial cells (polarized), donor1	11246-116E4	47.89	6.82	12.58	2.27	0.87	1.40	1.92	0.70	2.10
Iris Pigment Epithelial Cells, donor1	11530-119I9	36.09	1.92	2.88	0.69	0.00	0.41	0.69	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	187.85	12.74	19.10	0.00	28.66	0.00	3.18	0.00	25.47
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	93.45	6.68	26.70	0.00	6.68	0.00	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	216.67	54.17	135.42	0.00	27.08	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	181.35	22.15	22.15	0.00	13.84	1.38	1.38	1.38	23.53
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	137.65	2.50	20.02	0.00	5.01	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	213.63	0.00	35.60	11.87	11.87	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	294.73	15.38	23.07	0.00	23.07	7.69	2.56	0.00	17.94
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	242.25	18.28	45.71	0.00	0.00	9.14	4.57	0.00	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	230.65	17.87	19.49	0.00	14.62	6.50	0.00	1.62	8.12
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	270.10	11.67	21.67	1.67	10.00	5.00	1.67	0.00	13.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	199.68	3.63	29.04	0.00	7.26	10.89	3.63	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	304.40	14.56	47.64	2.65	14.56	1.32	1.32	3.97	11.91
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	268.29	4.43	16.63	2.22	12.20	3.33	3.33	0.00	13.30
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	340.49	15.71	57.62	0.00	15.71	0.00	5.24	0.00	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	275.25	15.12	33.38	0.63	9.45	0.63	3.15	0.00	8.82
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	250.55	13.92	24.75	0.00	9.28	3.09	6.19	1.55	27.84
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	292.69	14.63	87.81	14.63	14.63	0.00	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	310.10	18.09	46.51	1.94	13.57	2.58	5.81	0.65	19.38
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	326.81	6.44	37.03	1.61	20.93	4.83	9.66	0.00	28.98
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	477.93	71.69	71.69	0.00	11.95	11.95	0.00	0.00	35.84
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	290.91	23.63	44.00	0.81	14.67	8.15	6.52	0.81	10.59
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	185.98	13.85	19.73	1.68	12.17	2.94	2.94	1.26	5.04
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	388.06	43.12	28.74	0.00	43.12	14.37	0.00	0.00	86.23
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	239.50	14.47	36.17	2.41	22.50	4.02	5.63	0.00	20.09
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	156.03	13.85	20.31	0.92	9.23	1.85	1.85	0.00	11.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	301.62	60.32	90.48	0.00	30.16	45.24	15.08	0.00	30.16
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	110.46	11.80	23.60	1.89	12.27	2.83	2.36	0.00	3.30
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	129.70	7.26	26.30	0.91	8.16	1.81	3.63	0.91	7.26
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	221.14	29.48	117.94	0.00	44.23	0.00	44.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	172.18	22.60	25.83	1.08	19.37	4.30	3.23	1.08	21.52
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	185.49	11.43	34.30	0.00	16.52	0.00	7.62	0.00	20.33
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	131.44	65.72	0.00	0.00	32.86	16.43	49.29	0.00	32.86
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	161.97	17.22	40.17	1.28	15.94	5.10	3.83	0.00	15.30
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	191.38	10.94	30.99	1.82	21.87	0.00	9.11	0.00	21.87
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	205.46	63.22	110.63	0.00	15.80	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	190.66	15.00	29.99	2.14	15.00	0.00	3.57	0.00	15.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	222.33	23.23	39.82	0.00	13.27	13.27	9.95	0.00	36.50
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	83.39	83.39	0.00	20.85	20.85	0.00	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	100.62	8.64	15.43	2.16	6.17	1.54	0.62	0.00	7.41
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	212.48	10.54	33.36	1.76	15.80	5.27	1.76	1.76	36.88
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	251.45	6.29	37.72	3.14	28.29	6.29	0.00	0.00	25.15
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	146.73	7.65	20.17	0.70	20.17	1.39	2.78	1.39	15.30
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	84.10	17.70	59.75	0.00	4.43	8.85	0.00	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	126.44	35.66	19.45	0.00	6.48	3.24	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	83.71	21.80	44.47	0.87	6.10	2.62	1.74	2.62	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	123.74	20.25	40.50	0.00	18.00	6.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	97.57	27.88	45.30	0.00	13.94	3.48	0.00	0.00	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	93.88	20.27	34.14	0.00	5.33	3.20	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	117.76	26.32	27.71	0.00	5.54	2.77	2.77	1.39	6.93
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	136.78	19.95	45.59	0.00	19.95	5.70	2.85	2.85	19.95
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	93.88	12.89	30.37	1.84	7.36	2.76	0.92	0.92	6.44
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	54.46	33.28	45.38	0.00	6.05	3.03	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	18.63	43.46	0.00	18.63	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	84.59	16.92	33.84	0.00	6.34	4.23	0.00	1.06	2.11
Keratinocyte - epidermal, donor1	11272-116H3	59.00	7.43	6.45	1.22	0.24	0.82	0.57	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	68.52	2.93	0.00	0.59	0.00	1.17	1.17	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	47.52	4.83	3.31	0.47	0.19	0.38	0.76	0.47	0.47
Keratinocyte - oral, donor1	11251-116E9	71.06	8.97	6.13	0.91	0.34	1.36	0.45	0.34	0.91
Keratocytes, donor1	11527-119I6	113.46	6.53	6.88	1.03	2.06	0.69	3.44	0.69	0.00
Keratocytes, donor2	11607-120I5	51.56	5.86	1.17	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	53.15	2.77	4.74	1.78	0.40	0.20	0.40	0.00	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	41.76	2.20	10.99	2.20	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	49.62	1.08	3.24	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	45.56	8.88	7.50	0.69	1.38	0.81	0.58	0.35	0.35
Lens Epithelial Cells, donor3	11690-122I7	34.01	1.41	1.61	0.71	0.20	0.20	0.30	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	39.01	2.85	4.27	0.83	0.24	0.24	0.71	0.95	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	34.61	1.95	4.19	0.56	0.28	0.00	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	36.52	4.88	3.94	1.26	0.31	0.31	0.94	0.79	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	42.48	2.15	1.08	0.54	0.54	0.00	0.00	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	37.50	2.21	2.84	0.63	0.00	0.32	0.32	1.26	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.08	2.48	4.31	0.65	0.65	0.11	0.65	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	43.50	2.46	3.69	0.00	0.00	0.00	0.00	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	46.77	1.52	4.30	0.25	0.51	0.00	0.25	0.51	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	31.81	3.38	3.66	0.70	0.00	0.42	0.42	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	61.31	1.19	1.98	0.40	0.79	0.00	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	52.74	0.97	4.46	1.55	0.78	0.00	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	35.36	2.96	2.41	0.19	0.93	0.19	0.37	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	36.58	2.09	1.74	0.35	0.35	0.00	0.70	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	47.23	1.19	3.82	0.00	0.72	0.00	0.48	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	37.63	3.57	4.53	0.41	0.27	0.27	0.41	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	54.82	1.54	4.00	0.62	0.62	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	38.34	0.62	4.68	0.62	0.62	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	42.09	4.21	3.29	0.91	0.18	0.37	0.18	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	37.52	1.97	4.61	0.00	0.00	0.00	0.33	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	42.76	2.34	4.69	0.00	0.59	0.29	0.59	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	43.31	1.99	2.24	0.25	0.50	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	47.04	3.88	4.36	0.48	0.48	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	61.13	2.42	4.58	0.54	0.00	0.00	0.54	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	37.24	2.42	2.42	0.91	0.30	0.15	0.91	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	46.14	3.63	2.59	4.15	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	58.42	2.30	6.70	1.47	0.21	0.21	0.63	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	37.89	2.86	3.46	0.30	0.30	0.00	0.45	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	66.04	4.82	2.06	0.00	0.00	0.00	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	46.85	1.69	5.08	0.00	0.56	0.19	0.75	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	33.93	2.86	3.92	0.64	0.21	0.21	0.64	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	44.10	2.42	2.91	1.45	0.00	0.00	0.48	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	57.56	2.65	2.98	0.66	0.33	0.66	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	38.28	2.60	3.22	0.74	0.37	0.25	0.25	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	37.02	1.85	5.18	1.48	1.48	0.00	0.74	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	37.06	3.21	2.72	0.00	0.74	0.25	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	34.51	2.34	3.30	0.69	0.69	0.27	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	39.88	3.22	2.25	1.61	0.32	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	56.30	2.13	6.09	1.83	0.61	0.00	1.22	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	41.71	3.50	3.78	0.56	0.56	0.28	0.56	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	37.69	4.98	4.27	0.36	0.36	0.36	0.36	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	58.17	0.48	3.88	1.94	0.00	0.00	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	38.75	1.40	2.96	0.93	0.16	0.00	0.47	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	35.09	1.79	5.37	0.72	0.72	0.36	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	56.84	3.27	5.55	0.33	0.65	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	32.72	2.35	2.35	0.47	0.47	0.24	0.94	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	42.82	2.97	4.33	0.74	0.62	0.25	0.87	0.87	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	45.85	0.51	3.84	0.77	0.77	0.26	0.51	0.77	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	27.75	2.09	2.69	0.60	0.90	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	106.50	29.46	13.60	0.00	2.27	2.27	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	142.69	17.64	7.67	1.53	0.00	0.77	2.30	0.00	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	155.87	19.30	14.10	0.00	0.00	2.97	1.48	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	196.75	26.23	17.35	1.69	0.85	0.42	2.12	0.42	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	144.88	21.80	11.25	2.11	0.70	2.81	2.11	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	174.65	13.08	14.94	1.87	0.00	3.74	2.80	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	143.24	16.49	17.00	2.58	0.52	0.52	2.58	0.00	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	166.52	17.84	11.89	3.57	0.00	3.57	3.57	0.00	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	110.38	23.75	14.70	1.81	0.00	1.36	1.36	0.45	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	135.53	12.80	15.41	2.62	0.29	1.45	1.16	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	119.75	10.35	13.06	2.70	0.45	1.80	2.25	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	144.97	26.56	15.85	2.03	0.27	1.90	3.79	0.14	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	139.16	21.05	10.78	0.51	0.51	1.54	1.03	0.51	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	120.68	14.11	12.70	3.53	1.06	2.47	1.76	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	101.28	11.99	12.66	2.00	0.67	2.00	3.33	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	166.57	29.03	15.79	1.53	0.51	3.06	1.53	0.00	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	125.13	18.14	9.61	2.40	0.27	1.33	1.07	0.27	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	155.31	16.25	15.12	1.51	0.19	2.46	2.08	0.57	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	191.43	16.57	13.50	3.68	0.61	1.84	2.45	0.00	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	209.56	13.05	9.79	3.26	0.82	1.63	1.63	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	147.64	17.49	16.03	4.37	1.04	1.25	0.83	0.21	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	126.40	15.13	13.45	5.32	0.28	0.84	1.12	0.28	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	195.76	14.42	13.39	2.06	0.00	0.00	3.09	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	158.51	17.13	16.55	7.26	0.58	0.87	2.03	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	115.39	15.84	13.15	4.48	0.30	1.49	1.79	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	121.72	12.72	11.62	1.66	0.55	1.66	2.21	0.00	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	218.10	22.27	16.61	5.30	0.71	0.71	3.53	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	149.72	19.91	15.12	2.58	0.74	2.58	2.58	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	161.18	16.12	14.97	0.00	0.00	1.15	2.30	0.00	4.61
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	186.50	19.96	14.20	3.07	0.38	1.54	4.22	0.00	3.07
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	179.46	21.51	10.76	2.83	0.57	1.70	2.83	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	164.91	19.69	4.10	1.64	0.00	2.46	4.10	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	221.42	23.50	21.24	2.26	0.90	1.36	2.26	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	177.38	23.70	8.62	4.31	0.72	2.15	2.87	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	176.27	11.20	11.95	4.48	0.75	0.75	1.49	0.00	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	205.49	19.69	17.46	6.32	0.74	1.11	1.86	0.37	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	138.70	15.51	9.91	2.58	0.00	0.86	2.15	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	177.25	17.13	13.70	1.71	0.86	3.43	1.71	0.00	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	187.58	18.99	12.66	5.00	0.00	1.00	2.00	0.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	200.90	27.75	19.91	4.83	1.21	0.60	3.62	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	182.73	14.93	13.51	1.42	0.71	0.71	2.13	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	190.76	18.22	9.28	5.16	0.34	1.37	1.72	0.00	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	177.13	24.69	9.66	6.98	0.00	1.07	0.54	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	174.40	22.22	9.43	3.37	1.35	1.35	1.35	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	203.72	18.89	17.78	7.41	0.37	1.85	1.85	0.37	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	82.57	27.91	17.44	1.16	1.16	2.33	4.65	0.00	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	195.68	25.39	12.69	2.12	1.06	2.12	1.06	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	208.08	18.81	12.40	6.80	0.40	2.80	1.20	0.00	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	209.34	28.35	22.53	2.91	1.45	6.54	5.81	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	237.62	34.49	24.53	3.83	1.53	6.90	3.07	0.77	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	236.77	28.12	19.73	1.97	0.99	3.45	5.43	0.00	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	224.88	21.64	20.70	1.88	0.00	0.94	4.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	224.26	23.13	22.12	1.51	0.00	4.02	2.51	0.00	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	221.26	27.94	16.22	3.15	0.45	1.35	4.06	0.00	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	232.35	24.10	18.93	6.88	1.72	1.72	0.00	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	212.43	16.03	19.60	2.23	0.45	2.67	3.56	0.00	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	244.78	17.99	19.16	5.47	0.00	3.91	5.08	1.17	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	178.13	27.71	15.83	1.32	2.64	1.32	1.98	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	169.69	19.20	19.72	4.15	1.56	1.56	1.56	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	200.41	17.94	16.63	6.13	1.31	0.44	1.31	0.44	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	172.20	17.89	14.54	3.91	0.56	1.68	3.35	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	179.75	19.43	14.13	2.65	0.88	0.88	2.21	0.44	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	210.60	18.90	14.66	5.40	0.39	1.16	2.31	0.77	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	181.27	18.23	13.17	4.56	0.00	3.04	1.52	0.51	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	214.84	14.90	16.34	2.88	0.00	2.88	1.44	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	206.33	14.71	17.09	4.37	0.80	1.19	2.78	0.00	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	197.48	21.27	15.19	2.43	0.61	2.43	1.22	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	166.01	15.22	14.53	1.38	0.69	0.69	3.46	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	220.77	14.06	12.16	4.94	1.14	1.14	4.18	0.00	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	182.30	18.07	18.59	3.10	0.52	1.55	3.61	0.00	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	172.93	12.09	7.26	1.81	0.00	3.02	3.02	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	217.71	17.75	11.09	6.65	0.32	0.63	3.49	0.00	2.22
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	232.43	22.92	13.86	3.20	1.60	0.53	3.20	0.00	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	182.17	18.39	17.24	2.30	1.72	0.57	3.45	0.57	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	256.60	18.00	21.60	7.20	1.03	2.06	2.57	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	224.94	17.68	13.44	7.07	0.71	1.41	2.12	0.71	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	214.51	18.73	10.21	3.97	0.57	2.27	4.54	0.00	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	218.00	22.05	12.48	4.16	0.83	3.33	2.50	0.00	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	226.30	20.36	19.58	3.13	1.57	3.13	5.48	0.00	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	193.74	14.20	7.10	3.34	1.25	0.84	2.92	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	223.03	14.87	17.66	5.58	0.46	1.39	4.65	0.46	3.72
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	220.79	15.39	10.04	4.68	2.68	2.01	2.01	0.00	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	176.43	18.18	9.62	4.28	1.07	1.07	0.53	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	213.36	18.18	9.29	4.45	0.40	1.62	2.42	0.00	3.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	225.77	18.36	19.27	3.67	0.92	0.92	1.84	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	202.72	23.12	15.11	7.11	0.89	0.89	1.78	0.89	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	268.41	19.38	11.97	1.71	0.57	1.71	1.14	0.57	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	223.17	15.34	15.34	3.07	1.53	0.77	4.60	0.00	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	190.96	12.59	7.66	3.28	1.09	3.28	2.19	0.00	3.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	245.44	19.60	8.02	4.45	0.89	0.89	2.67	0.00	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	175.99	20.54	9.62	1.56	0.52	2.86	2.60	0.26	2.08
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	192.96	20.56	13.26	4.64	2.65	0.00	1.99	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	288.93	29.10	10.39	4.16	0.00	2.08	2.08	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	22.34	15.73	8.89	0.23	0.68	2.05	0.23	0.46	0.68
Macrophage - monocyte derived, donor2	11313-117C8	23.31	5.32	5.14	0.37	0.18	0.92	0.55	0.73	0.73
Macrophage - monocyte derived, donor3	11389-118C3	30.28	8.91	4.72	0.39	0.66	0.66	0.39	1.05	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.55	2.12	4.78	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	49.91	5.23	3.96	0.95	0.16	0.63	0.95	0.63	0.32
Mallassez-derived cells, donor3	11930-125I4	51.29	3.06	4.45	1.53	0.14	0.69	1.53	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	93.86	10.06	5.68	0.80	0.80	0.80	0.40	0.30	0.90
Mammary Epithelial Cell, donor2	11350-117G9	71.52	5.79	3.19	0.29	0.58	0.58	2.03	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	35.67	4.74	3.49	0.25	0.00	0.25	0.00	0.25	0.50
Mast cell - stimulated, donor1	11487-119E2	168.81	0.00	2.71	2.71	0.68	0.00	6.10	0.00	1.36
Mast cell, donor1	11563-120D6	68.67	32.33	21.63	2.27	2.05	3.14	1.62	2.60	0.97
Mast cell, donor2	11565-120D8	213.07	77.27	37.44	4.75	5.35	4.75	3.27	3.27	3.27
Mast cell, donor3	11566-120D9	181.23	77.89	38.50	2.93	4.73	4.50	3.60	3.38	5.18
Mast cell, donor4	11567-120E1	212.57	76.59	40.07	2.66	3.37	4.43	3.37	4.08	2.66
Mast cell, expanded and stimulated, donor5	11940-126A5	76.18	21.96	24.62	2.55	1.33	1.33	0.89	1.55	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	65.37	21.60	20.43	5.25	4.09	0.58	4.09	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	53.12	32.47	20.19	1.38	1.84	2.41	0.34	1.72	0.57
Mast cell, expanded, donor8	11941-126A6	100.25	45.86	20.59	2.18	1.84	3.01	1.00	1.51	0.33
Melanocyte - dark, donor1	11502-119F8	24.97	2.79	3.68	0.60	0.50	0.80	0.00	0.99	0.40
Melanocyte - dark, donor2	11582-120F7	35.65	2.08	2.08	0.69	0.00	0.00	2.08	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	38.68	7.39	6.81	0.51	0.43	0.58	0.80	1.52	0.29
Melanocyte - light, donor1	11274-116H5	28.91	5.64	6.35	0.71	0.71	0.24	1.18	0.24	0.24
Melanocyte - light, donor2	11351-117H1	27.98	8.87	5.46	1.36	0.68	0.68	0.68	1.36	0.00
Melanocyte - light, donor3	11423-118G1	43.36	2.60	6.07	0.00	0.87	0.00	2.60	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	40.09	7.60	7.91	1.35	0.42	0.62	0.31	1.04	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	27.70	5.11	5.11	0.81	0.81	0.00	0.54	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	35.62	10.98	8.04	0.54	1.07	0.54	0.54	2.14	0.00
Meningeal Cells, donor1	11493-119E8	87.21	6.08	8.19	0.25	0.62	0.74	1.98	0.74	0.12
Meningeal Cells, donor2	11573-120E7	68.22	4.40	1.76	0.44	0.44	0.88	1.32	1.32	0.00
Meningeal Cells, donor3	11654-122E7	60.39	2.61	3.42	0.73	0.16	0.08	1.14	0.16	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	29.94	3.99	5.70	1.71	0.29	0.29	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	29.18	1.31	2.11	0.20	0.10	0.20	1.01	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	36.80	3.94	10.51	1.31	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	39.24	2.62	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	49.51	2.87	2.15	1.44	0.00	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	37.91	3.60	4.02	0.64	0.00	0.42	1.27	0.64	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	37.20	4.02	4.02	1.01	0.50	0.00	1.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	59.99	6.15	4.18	0.66	1.10	0.22	0.44	1.54	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	65.02	2.92	5.11	2.19	1.46	0.00	1.46	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	66.70	5.12	4.91	0.20	1.43	0.00	1.43	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	33.52	6.23	3.88	0.69	0.28	0.69	1.25	0.42	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	34.57	8.18	8.18	0.37	0.37	2.23	0.00	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	38.42	7.11	4.47	0.53	0.26	0.26	1.05	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	42.14	5.64	3.86	0.89	0.59	0.30	1.48	0.59	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	60.72	7.01	4.67	2.34	0.00	2.34	9.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	55.07	4.48	4.48	1.92	0.00	0.00	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	36.15	1.42	3.54	0.00	0.00	0.35	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	28.46	7.51	4.07	0.00	0.00	0.31	2.50	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	36.28	2.90	2.90	0.00	0.73	0.73	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	31.56	4.24	4.51	0.80	0.27	0.80	2.65	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	20.02	0.50	3.50	0.00	0.00	0.50	2.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	41.12	2.17	2.46	0.87	0.22	0.29	1.08	0.07	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	9.45	4.05	0.00	1.35	2.70	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	28.57	8.37	4.68	0.49	0.25	0.99	0.99	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.04	6.18	4.12	0.29	0.88	0.59	0.88	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	24.20	0.00	0.00	0.00	0.00	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	23.56	8.37	4.03	0.62	0.93	0.31	1.24	0.93	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	28.42	5.39	5.60	0.41	0.21	0.21	0.62	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	9.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	35.29	6.51	3.25	0.75	0.25	1.25	0.75	1.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	36.77	6.05	7.91	0.93	0.00	0.47	0.47	0.47	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	36.99	5.49	4.88	0.41	0.00	1.63	0.61	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	33.26	4.75	3.56	0.00	0.40	0.40	0.79	1.58	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	34.21	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	25.66	3.54	0.88	0.00	0.00	0.00	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	39.89	3.42	4.56	0.00	0.38	0.38	0.76	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	3.95	1.32	1.32	0.00	0.00	1.32	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	36.71	3.18	1.70	0.64	0.00	0.21	0.64	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	21.18	2.76	0.92	0.92	0.00	0.00	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	25.33	3.87	2.38	0.30	0.00	0.89	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	23.47	3.35	1.68	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	32.62	4.27	1.25	0.25	0.50	0.75	1.25	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	43.73	4.52	3.57	0.24	0.48	0.48	1.43	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	6.08	1.66	0.00	0.00	0.00	2.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	37.07	4.37	3.22	0.92	0.23	0.23	2.53	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	53.22	3.79	3.37	0.21	0.21	0.63	0.84	0.63	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	36.89	4.48	3.26	0.41	0.82	1.22	1.83	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	25.74	3.86	3.00	0.43	0.21	0.64	1.50	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	51.13	3.56	2.22	0.67	0.00	0.00	1.11	1.11	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	29.79	4.38	1.53	0.66	0.44	0.22	1.10	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	35.49	5.07	2.03	0.00	0.00	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	9.94	0.00	0.00	1.66	1.66	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.92	3.81	3.53	0.27	1.36	0.00	1.63	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	51.46	8.53	1.76	0.59	0.29	0.29	1.47	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	10.90	1.09	0.00	0.00	2.18	2.18	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	30.76	3.84	4.32	0.00	0.00	0.48	1.92	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	50.03	6.40	6.80	1.20	0.00	0.40	2.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	15.08	10.97	1.37	0.00	0.00	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	35.54	5.01	1.50	0.00	0.00	1.50	1.50	0.00	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	33.28	4.38	4.82	0.00	0.00	0.44	3.94	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	6.62	2.21	0.00	0.00	0.00	1.10	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.01	7.04	4.48	0.00	0.64	1.92	0.00	0.64	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	41.90	6.20	4.46	0.25	1.49	0.99	1.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.09	5.57	4.87	0.70	0.00	1.39	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	26.52	17.68	4.42	0.00	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	47.86	5.81	5.47	0.34	1.03	0.68	4.10	1.37	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	23.19	6.56	1.75	0.00	0.44	0.44	0.88	0.00	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	18.82	7.10	2.84	0.36	0.36	0.36	2.13	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	51.06	7.86	4.21	0.56	0.28	0.84	2.24	0.28	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	27.02	5.40	4.57	0.00	0.83	1.25	1.25	1.66	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	23.31	8.16	0.58	0.00	0.58	1.17	1.75	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	49.17	7.24	4.83	0.90	0.90	0.90	1.21	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	49.25	4.59	0.83	0.83	0.00	0.83	1.25	1.25	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	7.22	0.00	0.00	0.00	21.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	9.24	3.69	3.69	3.69	0.92	2.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	51.22	3.41	2.85	0.57	0.00	1.71	1.71	2.85	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	27.36	4.42	2.07	0.14	0.28	0.69	1.11	0.41	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	48.98	6.74	3.37	1.30	2.33	1.81	2.07	1.04	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	51.48	4.29	4.72	0.43	0.43	1.29	0.43	1.72	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.06	8.89	3.18	0.00	0.00	0.64	2.54	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	25.35	5.87	3.20	1.07	0.80	0.80	2.94	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	56.87	8.68	4.49	0.60	0.00	2.39	1.20	1.80	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	27.69	5.51	3.96	0.57	0.14	0.99	1.41	0.57	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	43.95	7.96	4.78	0.32	0.32	0.32	0.64	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	58.38	5.97	3.76	1.11	0.66	1.11	0.88	0.44	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	28.82	7.96	2.28	0.38	0.38	1.14	1.14	1.52	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	46.31	8.52	5.11	0.57	0.57	1.70	3.13	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	70.30	6.15	7.37	1.23	0.25	1.47	1.72	1.47	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	20.20	11.08	3.26	0.65	1.30	1.96	1.30	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	32.05	9.11	5.29	0.88	0.88	1.47	1.76	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	66.32	6.92	7.78	0.29	0.29	0.86	1.73	0.86	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	25.14	14.84	5.77	0.82	0.00	0.41	1.24	1.24	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	26.20	8.93	5.06	0.60	0.00	0.00	0.60	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	7.53	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	8.91	1.78	0.00	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.06	9.20	5.59	1.64	0.33	0.99	0.99	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	14.73	5.26	3.16	2.10	0.00	0.00	0.00	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	20.95	18.38	6.52	0.20	0.99	1.78	0.20	0.20	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.01	13.97	3.73	0.00	0.93	0.93	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	24.41	12.77	5.63	1.88	2.25	0.38	0.38	1.13	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	22.11	7.46	2.66	0.80	0.53	1.07	0.27	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.53	14.36	7.58	0.34	0.79	1.58	0.68	0.34	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	20.63	10.31	2.21	0.74	0.74	0.00	0.00	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.22	6.96	3.66	1.10	0.37	1.47	0.37	0.73	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	28.00	9.33	1.56	3.11	0.00	3.11	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.55	6.41	5.34	0.00	1.07	1.07	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	7.73	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	15.15	3.03	1.01	1.01	4.04	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.49	3.37	2.11	0.42	0.42	0.42	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	156.62	17.71	5.45	0.00	0.00	0.00	6.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	44.51	6.99	0.64	0.00	0.00	0.64	3.18	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.87	7.29	2.43	0.00	0.00	1.62	5.67	0.81	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	148.02	10.57	6.04	0.00	1.51	0.00	3.02	3.02	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	993.57	119.91	45.68	0.00	0.00	5.71	22.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	782.99	29.36	6.52	3.26	3.26	6.52	16.31	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	294.65	14.26	0.00	0.00	0.00	4.75	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	489.41	25.10	37.65	12.55	0.00	0.00	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	35.33	5.60	3.23	0.86	0.00	0.43	1.72	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	40.76	7.84	4.70	2.09	1.05	0.52	1.05	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	25.36	2.67	2.00	0.67	0.00	0.67	2.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.69	3.34	2.09	1.25	0.00	0.00	1.25	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	62.37	6.46	5.32	1.52	0.38	0.19	2.47	0.76	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	25.53	6.38	9.58	0.00	0.00	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	17.68	0.68	0.68	0.68	0.68	0.00	1.36	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	51.45	9.19	5.51	0.00	0.00	1.84	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.97	2.93	2.09	0.42	1.26	0.42	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	24.64	3.25	2.79	1.16	0.46	0.00	1.39	0.46	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	32.16	1.62	1.08	0.81	0.54	0.27	0.81	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	29.43	5.05	1.47	0.42	0.21	1.05	1.47	0.21	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	28.29	4.96	1.99	0.50	0.00	0.00	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.03	3.79	3.52	0.81	0.00	0.54	0.81	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	24.71	2.04	2.49	1.13	0.23	0.45	0.00	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	29.56	4.57	2.29	0.98	0.33	0.16	0.49	0.65	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.43	3.83	4.19	1.09	0.55	0.55	0.73	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.22	1.06	1.59	0.53	0.00	0.00	1.59	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.81	2.40	0.00	0.00	0.00	0.00	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	41.35	2.63	6.24	2.63	0.66	0.33	0.98	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.44	1.79	1.95	0.98	0.16	0.16	0.49	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	28.40	2.47	3.00	0.35	0.18	0.53	1.23	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	22.50	2.81	0.70	0.70	0.00	0.00	0.70	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.79	5.06	4.14	1.38	0.46	0.00	2.30	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	26.99	3.53	4.82	0.32	0.64	0.96	1.61	0.96	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	67.94	4.14	6.21	2.76	1.38	0.34	0.34	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	60.68	2.53	5.06	0.00	0.00	2.53	5.06	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.05	4.68	2.23	0.45	0.45	0.22	1.34	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.78	4.23	2.96	0.85	0.42	0.00	0.42	1.69	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.60	3.09	4.03	0.00	0.00	0.00	0.95	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.46	3.43	0.86	0.86	0.43	0.43	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	24.66	4.00	4.33	0.33	0.67	0.00	2.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	20.29	4.06	2.25	0.45	0.00	0.45	1.35	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.87	1.98	2.78	0.40	0.40	0.40	1.19	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	28.79	2.79	7.43	0.00	0.00	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.89	4.16	3.41	0.76	0.00	0.38	0.38	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	24.77	2.61	1.63	0.98	0.98	0.00	0.98	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.12	4.36	2.18	0.87	0.00	0.00	0.44	0.87	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.64	2.71	1.81	0.45	0.45	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	25.58	4.41	1.76	0.88	0.88	0.00	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	18.62	1.33	3.32	1.33	0.00	0.00	1.33	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	22.32	4.96	2.48	0.50	0.00	0.50	0.99	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	20.29	7.66	2.30	0.00	0.38	0.77	0.77	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	23.29	7.86	10.89	1.21	0.91	0.60	1.21	0.60	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	31.39	2.65	2.43	0.44	0.22	0.44	0.88	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.30	4.74	1.36	0.00	0.00	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	10.22	20.44	0.00	5.11	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.07	2.44	2.44	0.00	1.22	0.61	2.44	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.20	5.04	0.63	0.63	0.00	0.00	0.63	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.88	4.24	0.91	0.30	1.21	0.00	0.61	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.94	3.96	0.79	0.79	0.00	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	55.55	6.80	4.53	2.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	0.00	35.41	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	33.29	3.35	3.73	0.50	0.25	0.50	1.61	0.25	0.25
Myoblast, donor2	11322-117D8	48.33	6.90	6.14	1.34	0.77	0.96	0.96	0.19	0.19
Myoblast, donor3	11398-118D3	37.16	5.04	4.88	0.50	0.50	0.67	0.50	0.17	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	179.94	7.73	5.55	2.04	1.17	0.29	0.15	1.75	1.02
Natural Killer Cells, donor1	11230-116C6	205.11	27.06	17.22	2.15	3.69	2.77	0.92	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	299.75	18.70	15.38	6.33	3.32	1.51	0.60	0.60	0.30
Natural Killer Cells, donor3	11387-118C1	275.53	25.95	15.83	4.97	3.31	3.87	0.55	1.66	0.18
Neural stem cells, donor1	11275-116H6	99.08	20.69	11.61	2.18	2.18	1.09	0.36	1.45	1.81
Neural stem cells, donor2	11352-117H2	119.39	17.33	9.63	0.00	7.70	0.00	0.00	5.78	1.93
Neurons, donor1	11494-119E9	88.76	7.97	31.86	2.28	3.41	0.00	1.14	0.00	0.00
Neurons, donor2	11574-120E8	41.17	7.71	15.19	1.54	2.20	3.08	0.22	1.98	0.66
Neurons, donor3	11655-122E8	65.77	9.04	9.87	2.47	4.11	1.64	3.29	3.29	0.00
Neutrophils, donor1	11233-116C9	205.09	66.82	1.86	7.42	8.35	2.78	1.86	3.71	0.00
Neutrophils, donor2	11314-117C9	237.71	72.47	0.00	14.49	5.80	2.90	0.00	2.90	2.90
Neutrophils, donor3	11390-118C4	226.62	62.31	1.22	4.89	1.22	9.77	1.22	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	54.14	6.77	3.92	1.07	0.47	0.95	0.36	0.36	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	48.51	6.19	4.56	1.30	0.00	0.65	0.33	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	24.47	5.01	3.81	0.60	0.00	0.20	0.40	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	35.10	5.64	6.19	0.83	0.28	1.38	1.51	0.00	0.41
Olfactory epithelial cells, donor2	11934-125I8	45.45	5.50	4.63	2.61	0.43	0.29	2.32	0.29	0.29
Olfactory epithelial cells, donor3	11935-125I9	37.57	6.58	3.86	1.02	0.45	1.02	1.14	0.23	0.68
Olfactory epithelial cells, donor4	11936-126A1	35.65	6.33	4.19	0.78	0.19	0.68	0.58	0.19	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	48.15	6.02	4.21	0.60	0.60	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	28.50	4.25	3.40	0.21	0.00	0.43	0.64	0.64	0.21
Osteoblast - differentiated, donor2	11353-117H3	19.43	6.86	1.14	1.14	0.00	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	26.69	6.83	3.10	0.62	0.62	2.48	1.86	0.62	0.62
Osteoblast, donor1	11277-116H8	39.87	7.23	5.28	0.78	0.78	0.20	1.95	0.39	0.39
Osteoblast, donor2	11354-117H4	56.19	6.32	3.51	0.70	0.70	0.00	2.81	0.00	0.00
Osteoblast, donor3	11426-118G4	68.43	3.91	6.40	1.42	0.36	0.71	1.24	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	34.96	6.40	6.99	1.01	0.17	0.17	2.02	0.25	0.25
Pericytes, donor1	11491-119E6	51.74	11.35	6.12	0.89	0.67	0.78	0.67	1.22	0.89
Pericytes, donor2	11571-120E5	51.61	12.00	8.83	1.13	1.81	0.68	0.91	1.13	0.68
Pericytes, donor3	11652-122E5	50.05	4.07	4.68	0.81	0.61	0.20	0.81	0.41	0.20
Perineurial Cells, donor1	11499-119F5	41.37	6.10	4.86	0.68	0.23	0.45	1.36	0.11	0.00
Perineurial Cells, donor2	11579-120F4	43.15	3.50	2.76	0.37	0.09	0.83	1.29	0.37	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	52.59	40.48	17.85	0.96	7.97	4.46	0.32	0.64	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	102.35	35.02	13.47	4.41	4.41	1.96	0.24	1.22	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	115.57	23.68	15.79	2.59	3.11	2.59	0.65	1.04	0.52
Placental Epithelial Cells, donor1	11278-116H9	126.04	15.07	8.13	0.96	0.96	0.72	1.20	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	39.92	14.42	9.98	1.11	1.11	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	47.71	15.12	10.99	0.59	1.37	1.37	1.18	0.79	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	28.16	2.53	3.16	0.95	0.00	0.00	0.00	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	32.08	4.13	5.82	0.75	0.19	0.00	0.94	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	60.43	5.48	6.66	0.26	0.13	0.52	4.18	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	46.16	4.95	7.88	0.68	0.45	0.23	0.90	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	46.99	4.58	6.07	1.17	0.11	0.32	0.96	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	37.97	4.36	4.36	1.31	0.00	0.44	0.00	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	51.71	3.44	5.59	1.43	0.57	0.43	2.01	0.29	0.14
Preadipocyte - perirenal, donor1	11469-119C2	42.32	2.95	2.95	0.98	0.00	0.98	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	46.37	4.30	4.61	0.00	0.00	0.00	0.92	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	70.30	3.54	2.66	2.30	0.53	0.00	1.06	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	45.47	3.92	3.41	0.68	0.17	0.00	0.68	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	49.74	4.38	5.50	0.47	0.00	0.28	1.77	0.28	0.28
Preadipocyte - visceral, donor2	11357-117H7	62.58	5.52	3.22	2.76	0.46	0.46	1.38	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	42.95	2.51	4.28	0.31	0.10	0.10	1.46	0.10	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	57.78	5.28	9.96	1.51	1.06	0.30	1.96	0.15	2.56
Prostate Epithelial Cells, donor2	11331-117E8	51.86	4.20	3.25	1.76	0.27	0.41	0.14	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	36.01	7.96	5.88	1.47	0.86	0.55	0.18	1.04	0.31
Prostate Stromal Cells, donor1	11254-116F3	42.37	3.08	5.01	0.68	0.34	0.34	1.82	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	57.20	3.23	4.30	1.97	0.36	0.18	1.43	0.36	0.54
Prostate Stromal Cells, donor3	11405-118E1	47.76	3.02	5.53	1.46	0.21	0.31	1.04	0.00	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	64.97	5.47	5.47	1.09	0.00	0.36	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	60.23	4.64	3.26	0.83	0.35	0.42	0.21	0.35	0.14
Renal Epithelial Cells, donor1	11517-119H5	58.84	3.04	4.06	0.51	1.01	0.51	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	63.31	7.82	9.96	0.71	0.00	1.42	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	66.17	6.99	4.98	0.42	0.42	0.11	0.32	0.21	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	38.13	2.72	4.77	1.36	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	38.68	3.91	4.18	0.67	0.67	0.13	0.94	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	46.40	2.89	4.44	0.67	0.00	0.00	0.67	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	45.92	3.33	4.66	0.00	0.00	0.00	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	58.32	4.40	6.38	0.44	0.88	1.10	0.88	0.44	0.22
Renal Mesangial Cells, donor2	11598-120H5	56.43	7.52	7.52	1.25	1.25	0.63	1.88	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	45.50	3.33	5.27	1.39	0.55	0.55	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	71.94	5.37	6.98	0.27	0.00	0.00	0.54	0.81	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	51.45	4.22	4.22	0.84	0.42	0.84	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	71.93	8.10	6.36	0.96	0.39	0.77	0.39	0.58	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	34.48	5.70	5.70	0.78	0.52	0.00	0.00	0.52	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	34.39	7.67	5.97	0.28	0.85	0.85	0.57	0.28	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	57.63	5.15	5.15	0.00	2.06	0.00	0.00	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	56.71	8.78	8.53	0.50	1.00	0.50	0.50	0.50	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	53.99	19.24	13.10	0.94	1.34	1.47	0.80	4.54	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	90.23	24.12	16.08	2.68	0.89	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	139.24	4.40	19.26	6.05	2.20	1.10	0.55	1.10	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	88.75	11.02	10.44	1.74	1.16	1.74	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	62.80	13.00	11.57	0.78	1.43	0.78	1.04	0.39	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	88.68	8.24	12.12	1.49	0.50	0.70	0.40	0.70	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	93.58	13.27	14.83	1.23	1.56	1.34	0.78	0.45	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	122.55	14.64	13.64	2.11	1.49	1.24	0.99	0.25	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	97.66	7.69	11.77	2.10	0.70	0.47	0.70	0.35	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	121.34	11.79	15.95	2.54	1.16	1.85	0.92	0.00	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	99.40	7.12	12.46	1.51	0.55	1.23	0.68	0.27	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	73.67	8.77	10.89	1.97	0.91	1.51	0.45	0.30	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	73.11	11.47	11.83	0.54	1.08	1.08	0.54	0.54	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	104.72	10.04	12.77	1.58	0.86	1.00	1.00	0.72	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	103.24	9.66	11.80	2.15	1.18	0.75	0.64	0.43	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	105.77	7.97	11.73	1.55	1.11	1.11	1.11	0.66	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	91.57	5.74	13.76	1.72	0.76	1.53	1.15	0.57	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	81.24	9.78	9.32	1.21	0.75	1.12	0.56	0.65	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	111.80	16.54	20.11	2.25	1.32	0.94	0.75	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	76.97	8.76	13.80	0.93	1.19	0.93	0.66	0.66	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	89.26	7.59	10.80	1.56	0.68	1.27	0.49	0.29	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	108.85	13.18	17.57	3.25	1.15	0.95	1.15	0.19	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	81.38	6.73	12.60	1.28	0.85	1.28	0.53	0.75	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	81.85	9.81	14.02	3.64	0.84	0.28	0.56	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	110.40	7.18	18.63	1.37	1.20	0.34	1.37	0.51	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	81.68	7.48	11.85	1.46	0.55	1.28	0.18	0.18	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	101.42	9.69	11.53	1.84	0.49	0.37	1.10	0.25	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	110.01	11.82	18.94	2.42	0.67	1.48	1.61	0.40	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	158.98	9.20	19.11	1.65	1.65	0.71	1.42	0.71	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	99.01	11.51	14.48	2.18	0.79	1.59	1.39	0.00	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	118.79	8.65	15.20	1.40	0.70	1.17	1.87	0.23	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	123.38	5.60	16.80	1.66	0.41	0.21	0.41	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	83.17	11.06	17.03	2.21	1.33	0.44	0.66	0.44	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	110.92	15.04	14.62	1.46	0.21	1.04	1.88	0.21	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	129.34	8.34	13.86	1.48	1.48	0.94	1.35	0.81	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	82.42	8.17	11.92	1.36	0.51	1.19	0.51	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	111.44	11.37	12.53	2.12	0.39	1.35	2.31	0.19	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	117.09	7.22	14.27	1.72	1.55	1.03	1.03	0.00	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	72.01	8.23	12.07	0.82	0.14	0.41	0.82	0.55	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	95.38	10.34	14.61	1.97	0.66	1.31	0.49	0.49	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	94.93	7.16	12.44	1.19	0.34	1.36	0.51	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	87.00	10.36	11.54	1.78	0.89	0.30	0.44	0.15	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	109.82	6.93	14.39	0.27	0.53	0.53	0.27	1.33	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	91.39	11.20	13.96	1.24	2.35	1.80	0.14	1.38	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	104.53	9.05	13.10	3.10	0.48	0.71	0.24	0.71	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	140.47	9.88	17.53	1.61	1.21	2.02	1.01	1.21	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	94.83	11.02	15.92	1.88	0.47	1.51	0.28	1.60	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	105.86	11.88	16.77	1.75	0.35	1.05	1.75	0.70	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	95.20	10.28	12.69	0.60	2.12	0.91	0.91	0.60	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	109.78	11.01	15.42	2.57	0.86	1.10	0.24	0.86	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	112.51	33.48	21.40	1.89	3.35	3.64	0.87	0.87	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	105.26	13.39	14.60	4.26	0.61	1.83	0.61	0.61	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	113.93	10.25	21.70	2.11	1.51	0.60	0.60	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	150.42	21.26	21.04	5.65	1.58	0.90	0.45	0.45	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	165.35	22.77	25.16	3.29	1.50	1.20	0.00	1.20	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	96.94	16.18	19.48	6.73	2.01	0.94	0.83	1.18	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	102.67	17.50	20.92	5.34	2.77	1.07	1.07	1.49	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	122.00	13.22	14.42	3.61	2.40	1.20	1.20	0.60	0.60
Schwann Cells, donor1	11498-119F4	54.54	4.51	6.02	0.56	1.13	0.19	2.07	0.38	0.75
Schwann Cells, donor2	11578-120F3	64.65	3.40	0.00	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	36.59	5.48	2.19	0.88	0.44	0.66	0.44	0.66	0.00
Sebocyte, donor1	11220-116B5	95.86	4.38	5.48	0.55	1.10	2.19	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	62.96	3.68	2.76	4.14	0.46	0.46	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	42.67	7.21	5.77	1.24	0.62	0.41	0.62	0.21	0.62
Sertoli Cells, donor1	11255-116F4	44.73	3.31	3.31	0.00	0.00	0.00	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	48.01	0.00	8.47	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	69.41	10.03	11.09	0.88	1.94	0.26	1.76	0.79	1.14
Skeletal Muscle Cells, donor2	11358-117H8	44.09	5.06	7.95	0.72	0.72	1.45	0.00	1.45	1.45
Skeletal Muscle Cells, donor3	11430-118G8	69.39	13.38	5.85	0.00	0.00	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	47.44	5.18	3.61	1.10	0.63	0.16	2.04	0.79	0.47
Skeletal Muscle Cells, donor5	11455-119A6	45.04	3.12	4.91	0.89	0.15	0.30	2.97	0.74	0.30
Skeletal Muscle Cells, donor6	11459-119B1	50.63	3.08	5.69	1.08	0.15	0.31	1.23	0.92	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	46.75	7.94	9.32	1.64	1.01	0.76	1.76	0.76	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	51.23	5.42	5.99	1.28	0.86	0.43	2.14	0.29	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	57.94	3.17	5.75	1.49	0.30	0.10	2.58	0.40	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	55.44	7.16	8.43	0.84	0.25	0.34	1.85	0.51	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	65.14	8.69	10.86	0.00	1.45	1.45	2.17	0.00	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	46.51	4.82	3.44	0.55	0.83	0.14	1.51	0.55	0.69
Skin - palm, donor1	10286-104F7	13.43	8.06	5.37	0.00	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	32.29	3.46	2.45	1.44	0.43	0.58	0.14	0.29	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	102.24	15.54	22.08	8.18	1.64	0.00	7.36	0.00	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	35.44	4.41	2.99	1.04	0.00	0.13	0.39	0.39	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	56.44	5.56	5.28	1.81	0.42	0.97	0.56	0.70	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	60.20	6.05	2.81	0.98	1.27	1.27	1.13	0.28	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	105.30	29.39	18.61	1.90	1.90	1.90	4.86	0.85	2.33
Small Airway Epithelial Cells, donor3	11406-118E2	62.28	9.82	5.02	1.20	0.60	0.60	0.30	0.60	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	52.77	1.54	1.54	2.16	0.31	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	51.80	8.67	7.11	0.67	0.22	0.44	3.56	0.00	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	31.15	5.88	5.29	1.18	0.00	0.59	2.35	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	56.79	6.19	5.08	0.22	0.00	0.44	2.21	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	36.62	2.76	2.36	0.00	0.39	0.00	0.00	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	43.26	4.64	10.04	0.00	0.77	2.32	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	71.05	6.00	7.01	0.00	0.00	2.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	35.66	1.86	1.60	0.27	0.13	0.13	0.67	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	34.13	3.10	4.65	1.33	0.00	0.00	1.55	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	23.05	2.56	2.18	0.38	0.26	0.26	1.79	0.26	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	24.74	7.81	3.58	0.65	0.00	0.00	0.33	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	32.78	3.84	1.77	0.00	0.00	0.00	0.59	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.75	3.42	2.14	0.00	0.14	0.14	0.71	0.28	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	54.50	2.60	4.39	0.33	0.16	0.00	0.98	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	41.71	2.74	5.48	1.52	0.61	0.61	0.30	0.30	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	34.85	3.79	5.81	0.00	0.25	0.51	3.03	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	434.57	42.84	18.36	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	31.47	2.86	3.34	0.00	0.00	0.00	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	25.22	4.28	4.28	0.29	0.15	0.74	0.74	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	37.02	4.09	3.66	0.43	0.22	0.43	1.72	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.25	3.46	3.15	1.26	0.31	0.31	1.89	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	39.75	2.01	1.86	0.46	0.00	0.15	0.77	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	38.80	2.16	3.23	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	28.39	3.29	2.69	0.60	0.00	0.00	0.30	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	44.38	3.76	5.12	0.68	0.00	0.00	2.39	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	41.62	8.25	5.26	1.02	0.47	0.94	0.47	0.39	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	47.20	3.02	4.03	1.71	0.40	0.40	0.50	0.60	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	50.74	3.41	7.96	2.28	0.46	0.91	2.05	0.46	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	41.06	4.83	4.83	0.00	0.60	0.00	0.60	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	62.26	1.85	2.91	0.26	0.26	0.53	0.79	1.06	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	37.82	6.13	6.39	1.46	0.00	0.40	1.46	0.40	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	46.71	5.13	4.63	1.38	0.50	0.63	2.38	0.13	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	33.48	4.31	3.04	0.25	0.76	0.00	3.04	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.02	4.22	5.13	0.15	0.15	0.60	0.75	0.75	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	40.51	6.00	4.50	0.75	0.00	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	311.42	54.27	5.17	1.29	0.00	0.00	0.00	5.17	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	39.53	6.05	5.12	0.93	0.47	0.00	1.86	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	47.46	5.55	6.56	0.00	0.50	0.50	1.01	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	46.07	4.39	1.88	0.63	0.00	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	39.23	3.24	3.83	0.29	0.00	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	41.65	3.58	2.00	0.17	0.42	0.00	0.83	0.25	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	41.11	7.01	2.34	0.47	0.47	0.00	1.87	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	37.27	3.17	2.59	0.00	0.14	0.00	0.43	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	45.64	5.35	3.57	0.51	0.25	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	33.66	3.01	3.38	0.56	0.19	0.19	1.50	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	41.22	4.75	2.24	0.42	0.56	0.28	0.98	0.28	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	34.10	2.93	2.68	0.25	0.17	0.08	0.67	0.08	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	45.24	2.38	2.86	0.00	0.00	0.00	0.95	0.00	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	28.38	1.47	1.47	0.24	0.00	0.24	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	38.67	4.20	6.85	1.10	0.00	0.22	1.77	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	32.77	5.27	2.63	0.88	0.00	0.00	5.85	0.88	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	38.09	7.19	2.72	0.19	0.78	0.19	1.17	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.18	3.44	4.50	1.06	0.00	0.26	0.79	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	50.58	1.86	2.98	1.12	0.37	0.00	0.74	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	41.32	4.67	4.67	1.44	0.72	0.00	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	31.51	3.41	2.56	0.28	0.00	0.57	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	39.39	1.18	3.94	2.36	0.00	0.39	1.58	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	33.01	4.32	5.59	1.02	0.25	0.00	0.25	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	48.32	6.39	5.19	2.40	0.00	2.00	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	33.86	5.02	2.51	1.25	0.42	0.00	1.25	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	38.50	5.96	3.67	0.92	0.00	1.38	2.29	0.46	0.00
Synoviocyte, donor1	11291-117A4	88.54	3.20	6.06	1.35	0.17	0.34	1.85	0.17	0.00
Synoviocyte, donor2	11368-117I9	36.71	4.19	5.03	0.84	0.17	0.50	0.67	0.67	0.00
Synoviocyte, donor3	11440-118H9	23.01	7.60	4.02	0.67	0.67	0.67	1.34	0.22	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	81.83	8.93	10.72	1.43	0.36	0.00	2.14	1.79	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	77.30	5.95	3.96	1.98	1.98	1.98	1.98	0.00	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	75.95	6.48	6.71	0.69	0.46	0.69	1.85	0.23	3.01
Tracheal Epithelial Cells, donor1	11292-117A5	42.51	6.52	3.87	0.79	0.14	0.86	0.29	0.14	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	39.43	4.64	3.48	0.39	0.39	1.16	0.77	0.39	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	52.11	9.74	4.01	0.57	0.00	0.00	1.15	0.57	3.44
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	55.48	18.70	14.02	1.85	1.60	1.35	0.49	3.08	0.49
Urethra, donor2	10319-105A4	10.79	8.99	8.99	5.40	1.80	0.00	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	58.71	6.64	5.58	1.59	0.00	0.00	0.80	0.27	0.27
Urothelial Cells, donor2	11600-120H7	54.08	4.81	3.20	0.80	0.40	1.20	1.20	0.40	0.00
Urothelial Cells, donor3	11681-122H7	53.63	5.04	4.81	0.92	0.23	0.46	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	53.72	8.69	6.46	0.67	0.00	0.22	0.67	0.45	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	67.62	72.96	16.02	0.89	5.34	2.67	1.78	2.67	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	77.20	81.49	20.01	0.00	1.43	5.72	0.00	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	76.67	50.65	16.43	2.74	3.42	4.11	1.37	3.42	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	56.13	60.60	30.99	0.34	3.79	4.82	1.03	2.41	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	45.32	47.64	24.98	1.16	5.23	4.65	0.00	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	70.80	79.13	23.95	2.08	2.08	7.29	0.00	5.21	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	72.51	62.41	25.70	0.00	4.59	3.67	0.00	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	59.34	40.17	12.78	0.91	1.83	1.83	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	65.75	7.53	3.08	0.99	0.25	1.60	0.99	0.37	1.11
Wilms' tumor cell line:HFWT	10597-108E3	33.44	6.16	2.64	0.00	1.76	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	113.40	9.50	7.26	1.12	0.28	0.84	2.23	0.28	2.79
achilles tendon, donor2	10292-104G4	84.73	22.73	6.20	8.27	0.00	2.07	4.13	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	76.49	6.63	10.71	1.27	2.55	2.29	0.00	1.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	138.38	7.43	15.32	2.32	2.55	2.32	0.70	1.16	2.55
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	177.35	20.18	25.64	2.73	10.68	5.94	0.83	3.56	2.85
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	102.59	3.81	11.43	2.99	2.18	1.63	0.00	1.09	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	109.90	9.56	22.77	3.37	2.53	2.25	0.84	0.56	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	49.06	8.88	15.86	0.21	1.69	1.90	0.42	0.63	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	156.79	7.89	16.88	1.36	1.63	0.82	0.27	1.36	3.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	49.79	4.41	7.93	0.88	3.97	3.08	0.44	0.00	4.41
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	64.52	7.35	13.07	2.45	2.86	0.82	1.23	1.23	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	113.77	15.53	10.48	0.78	5.05	1.94	0.39	0.39	3.88
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	94.02	3.31	12.51	1.29	0.74	1.66	0.00	0.18	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	70.21	15.60	15.60	0.00	0.00	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	203.80	5.58	10.69	2.56	2.56	2.56	0.23	1.16	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	143.43	15.28	32.88	4.14	2.85	0.52	0.78	1.04	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	73.06	7.89	19.58	0.88	2.92	1.17	0.88	0.88	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	61.35	7.90	4.65	0.46	0.93	0.46	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	149.28	7.81	13.57	4.52	1.65	2.06	0.82	1.23	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	34.07	9.82	14.43	3.38	1.53	2.15	0.92	0.92	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	42.24	10.24	20.06	2.13	1.71	2.56	1.71	2.13	3.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	57.63	14.56	23.05	1.21	1.52	2.73	0.91	0.61	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	63.79	14.20	22.14	1.20	1.93	2.65	0.72	0.72	2.65
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	65.26	6.24	12.03	2.23	2.45	1.11	0.45	1.11	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	70.71	8.67	7.67	1.67	0.67	0.00	1.67	0.67	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	3.72	7.43	1.86	0.00	0.00	1.86	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	64.03	7.53	11.30	1.13	2.64	0.38	1.51	1.51	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	104.24	10.47	10.90	2.18	0.44	0.87	1.31	1.74	5.67
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	31.87	11.25	13.12	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	52.75	5.18	11.30	0.00	0.71	0.24	0.47	0.71	1.65
adipose tissue, adult, pool1	10010-101C1	33.97	18.92	10.08	1.24	1.55	0.16	0.78	1.24	0.62
adipose, donor1	10184-103D4	92.07	30.49	28.73	4.10	0.59	0.59	0.59	1.17	0.00
adipose, donor2	10185-103D5	78.67	10.54	11.35	1.22	1.22	0.41	1.22	1.62	0.81
adipose, donor3	10186-103D6	166.64	15.52	15.52	3.54	1.09	2.45	1.09	1.63	2.18
adipose, donor4	10187-103D7	162.95	18.20	23.40	7.80	1.73	0.87	0.87	2.60	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	38.03	2.53	7.58	0.63	0.32	1.10	0.47	1.26	1.42
adrenal gland, adult, pool1	10081-102A9	32.74	14.55	3.64	3.64	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	118.60	12.41	14.41	1.33	1.20	1.07	0.40	1.47	1.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	67.17	6.43	9.65	1.79	1.43	0.00	1.79	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	175.28	15.07	12.52	3.48	0.93	1.62	0.46	2.55	0.46
amniotic membrane cells, donor2	12236-129G4	43.95	24.68	20.96	1.35	1.01	1.01	0.34	3.04	0.68
amniotic membrane cells, donor3	12237-129G5	202.69	12.67	11.49	0.88	0.29	1.47	0.00	2.06	0.00
amygdala - adult, donor10196	10167-103B5	49.80	7.11	14.23	1.19	1.19	1.19	0.00	2.37	1.19
amygdala, adult, donor10252	10151-102I7	69.95	12.17	16.22	2.03	2.23	1.62	0.41	6.89	0.61
amygdala, newborn, donor10223	10360-105E9	63.26	10.97	10.97	2.26	1.94	0.65	4.20	1.61	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	119.69	9.93	9.42	1.53	1.27	0.51	1.40	0.38	1.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	87.15	11.91	9.93	1.54	1.54	1.10	0.88	1.10	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	238.17	18.04	16.37	5.68	1.00	3.67	0.33	1.00	7.01
aorta, adult, pool1	10052-101G7	47.07	29.62	10.59	1.96	2.35	2.55	0.59	3.33	0.98
appendix, adult	10189-103D9	74.13	22.90	15.14	0.78	1.94	4.27	1.16	1.94	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	164.40	5.85	25.80	3.78	1.72	2.75	0.00	1.72	2.75
artery, adult	10190-103E1	33.97	31.25	10.87	1.36	0.00	1.36	1.36	0.00	5.43
astrocytoma cell line:TM-31	10425-106D2	106.33	7.24	11.15	0.58	0.58	0.58	0.29	1.01	0.58
b cell line:RPMI1788	10427-106D4	120.75	11.30	19.48	2.38	4.01	1.34	2.08	1.34	1.78
basal cell carcinoma cell line:TE 354.T	10702-109G9	33.02	1.94	3.33	1.39	0.00	0.28	1.66	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	78.00	4.07	6.25	0.79	0.50	0.20	0.10	0.00	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	94.74	5.19	3.85	1.17	0.67	0.17	0.50	0.67	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	29.64	13.98	12.86	1.12	1.12	1.68	0.00	1.12	0.56
bladder, adult, pool1	10011-101C2	38.89	26.62	6.84	1.09	0.98	2.39	1.30	0.65	0.98
blood, adult, pool1	10053-101G8	39.86	33.22	4.43	0.00	2.21	6.64	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	20.55	3.43	3.43	0.00	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	73.56	24.29	12.15	9.45	4.72	2.02	2.02	2.70	0.00
brain, adult, donor1	10084-102B3	31.78	9.23	14.35	3.08	0.00	1.03	1.03	5.13	1.03
brain, adult, pool1	10012-101C3	32.85	8.02	15.48	0.67	1.34	1.34	0.56	2.12	2.00
brain, fetal, pool1	10085-102B4	61.44	24.04	18.70	5.34	5.34	5.34	2.67	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	77.97	15.86	4.63	3.96	0.00	1.65	0.33	0.66	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	88.75	12.61	9.99	0.50	0.12	2.25	0.75	0.62	2.00
breast, adult, donor1	10080-102A8	27.78	13.89	8.21	1.26	0.00	1.26	0.63	3.79	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	50.69	7.75	5.34	1.65	0.76	0.76	0.64	1.40	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	77.61	9.28	4.95	0.93	0.62	1.24	0.31	1.55	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	178.88	7.14	10.59	4.37	0.92	1.61	1.15	2.53	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	56.65	8.72	8.96	0.97	0.97	1.69	0.00	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	54.07	3.76	15.99	0.94	1.41	0.47	0.47	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	45.72	5.91	5.03	0.33	0.98	0.66	0.77	0.55	0.77
carcinoid cell line:SK-PN-DW	10719-109I8	116.30	4.12	8.87	1.90	1.27	2.22	0.00	0.63	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	142.94	21.56	23.96	4.53	3.46	1.86	3.19	2.40	1.60
caudate nucleus - adult, donor10196	10177-103C6	42.60	9.21	14.97	2.30	3.45	0.00	0.00	5.76	0.00
caudate nucleus, adult, donor10252	10164-103B2	52.54	10.04	13.55	2.84	1.34	0.50	0.50	4.18	0.84
caudate nucleus, adult, donor10258	10379-105H1	40.50	7.64	16.81	3.06	0.76	0.76	0.76	5.35	2.29
caudate nucleus, newborn, donor10223	10354-105E3	62.99	15.38	12.82	2.20	1.46	0.00	2.93	2.93	0.00
cerebellum - adult, donor10196	10173-103C2	99.05	23.31	40.79	5.83	5.83	2.91	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	129.81	20.28	52.95	5.76	1.92	2.14	0.43	8.11	0.64
cerebellum, adult, pool1	10083-102B2	28.98	23.11	19.32	2.76	1.72	2.07	1.03	3.45	1.72
cerebellum, newborn, donor10223	10357-105E6	53.97	44.01	34.04	1.66	0.83	4.98	3.32	2.49	0.83
cerebral meninges, adult	10188-103D8	30.26	7.82	7.82	0.76	1.01	1.51	0.50	1.26	0.76
cerebrospinal fluid, donor2	10294-104G6	38.74	6.58	4.39	2.92	2.92	1.46	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	103.38	10.06	15.24	1.29	1.44	0.43	0.43	1.29	1.58
cervical cancer cell line:ME-180	10553-107I4	101.09	7.29	6.30	1.16	0.66	0.83	0.17	0.50	0.33
cervix, adult, pool1	10013-101C4	58.06	35.59	16.48	1.68	3.78	1.89	1.47	1.57	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	51.28	4.88	5.85	0.42	0.70	0.56	2.23	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	11.76	3.92	0.00	1.31	0.00	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	100.29	12.18	22.37	2.24	2.73	1.99	0.25	3.36	0.37
choriocarcinoma cell line:SCH	10785-110H2	52.12	11.71	13.43	1.11	2.96	1.60	0.37	1.97	1.48
choriocarcinoma cell line:T3M-3	10618-108G6	63.33	3.32	7.12	0.00	0.00	0.47	0.24	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	249.87	7.98	6.55	3.42	0.28	0.85	0.28	3.42	0.57
chorionic membrane cells, donor2	12239-129G7	42.46	10.34	7.26	0.89	0.40	0.99	0.50	1.09	0.10
chorionic membrane cells, donor3	12240-129G8	226.39	8.79	9.34	4.40	0.55	1.10	0.00	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	124.21	1.01	5.05	0.00	5.05	1.01	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	64.55	8.45	9.60	1.34	2.11	1.73	1.15	1.34	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	49.00	8.03	6.76	0.84	1.69	0.84	0.63	1.06	2.32
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	81.92	10.53	12.33	1.28	4.11	1.03	1.03	1.80	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	82.48	5.81	19.11	1.94	2.18	0.48	0.97	0.48	2.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	83.28	8.14	16.70	2.24	2.04	1.83	0.00	1.02	2.65
chronic myelogenous leukemia cell line:K562	10454-106G4	85.10	4.12	10.60	2.36	2.65	0.29	0.59	1.77	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	184.26	10.43	19.81	1.30	1.82	2.61	0.26	0.78	4.69
clear cell carcinoma cell line:JHOC-5	10638-108I8	103.32	2.97	7.31	2.06	0.23	0.69	0.23	0.00	1.37
clear cell carcinoma cell line:TEN	10636-108I6	126.31	5.21	7.63	2.60	0.35	0.52	0.17	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	66.81	5.31	9.88	0.92	1.65	0.55	0.18	0.37	1.83
colon carcinoma cell line:COLO-320	10420-106C6	177.12	8.74	26.23	2.28	1.14	1.52	0.38	2.66	0.76
colon, adult, donor1	10082-102B1	49.98	16.66	4.76	0.00	1.19	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	42.18	22.21	15.16	0.82	2.12	1.88	0.82	2.12	0.94
colon, fetal, donor1	10070-101I7	29.05	16.69	5.56	1.85	0.62	0.62	1.24	1.85	1.85
common myeloid progenitor CMP, donor1	12130-128D6	18.33	59.59	18.33	0.00	9.17	9.17	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	176.77	14.45	17.00	2.97	5.10	0.85	12.32	2.55	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	84.97	5.58	11.32	2.26	0.91	0.75	1.51	0.60	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	93.07	3.95	10.29	0.71	1.13	0.42	3.24	0.71	1.41
corpus callosum, adult, pool1	10042-101F6	70.32	26.87	21.01	1.88	3.10	1.77	0.88	3.21	3.98
cruciate ligament, donor2	10295-104G7	62.41	28.37	9.73	1.62	1.62	0.81	0.81	4.05	0.00
diaphragm, fetal, donor1	10069-101I6	18.46	8.03	7.22	1.61	0.80	0.00	0.80	0.00	0.80
diencephalon, adult	10193-103E4	35.28	3.36	9.36	1.68	1.44	0.96	0.00	2.16	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	68.88	8.73	14.01	3.67	3.21	3.67	0.46	1.61	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	74.37	8.46	9.23	0.77	0.00	1.28	0.51	0.77	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	53.44	4.57	1.69	2.17	0.24	0.96	2.41	0.00	3.61
ductus deferens, adult	10196-103E7	96.68	32.89	16.94	1.50	1.50	2.99	2.49	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	43.21	11.52	8.64	1.44	2.88	5.76	1.44	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	61.79	15.45	25.01	2.21	6.62	0.00	4.41	0.00	1.47
dura mater, adult, donor1	10041-101F5	29.73	29.65	17.34	0.66	2.48	1.16	1.40	1.57	1.57
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	652.45	72.40	64.85	17.10	2.89	5.55	11.55	0.22	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	287.30	9.89	13.47	5.16	1.72	1.15	1.43	0.86	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	66.59	1.85	2.47	0.62	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	72.05	4.54	4.84	1.21	0.00	0.00	0.91	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	54.03	5.87	4.94	0.00	0.00	0.31	0.62	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	51.23	2.63	2.63	1.31	0.00	0.00	1.31	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	80.78	5.36	5.03	0.34	1.68	1.01	1.34	0.00	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	65.79	7.43	12.32	1.81	0.54	1.63	1.27	0.72	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	64.33	0.00	2.25	1.77	0.00	0.00	0.00	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	74.92	10.12	4.45	0.78	0.22	0.67	0.56	0.11	1.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	114.60	9.57	9.02	1.21	0.33	0.66	1.32	0.33	0.77
epididymis, adult	10197-103E8	47.93	17.37	14.44	2.93	1.26	1.26	3.77	1.47	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	39.92	3.55	4.26	0.89	0.53	0.71	7.10	0.18	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	48.37	4.33	2.75	0.39	1.18	0.00	4.72	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	96.45	3.80	14.55	1.97	0.52	0.13	0.66	0.39	2.88
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	122.04	6.89	15.45	1.48	0.69	0.30	0.79	0.69	2.56
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	85.48	3.47	12.44	1.90	0.22	0.34	0.90	0.56	2.91
esophagus, adult, pool1	10015-101C6	40.03	16.35	7.22	1.27	1.59	1.06	0.42	1.59	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	70.26	2.38	8.64	0.38	0.63	0.13	1.50	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	14.49	19.32	7.24	14.49	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	8.42	6.31	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	7.44	7.44	4.46	1.49	0.00	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	30.96	9.17	8.03	0.00	2.29	1.15	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	52.47	13.12	5.83	0.00	1.46	0.00	2.91	1.46	1.46
eye, fetal, donor1	10054-101G9	42.20	11.95	10.42	0.76	3.05	0.51	1.02	2.03	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	62.83	1.92	3.97	0.77	0.38	0.64	0.00	0.13	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	61.49	6.17	6.89	1.19	0.47	0.95	0.71	1.42	3.09
frontal lobe, adult, pool1	10040-101F4	35.84	13.32	24.86	0.94	0.75	2.63	0.28	3.57	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	89.47	18.62	15.91	3.00	1.20	1.80	2.40	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	110.82	4.48	8.60	1.46	0.37	0.73	2.01	0.27	0.91
gall bladder, adult	10198-103E9	47.80	18.83	12.55	0.48	1.93	2.66	0.48	2.41	0.72
gamma delta positive T cells, donor1	11937-126A2	75.70	35.97	28.99	2.15	6.44	6.98	0.54	4.29	0.54
gamma delta positive T cells, donor2	11938-126A3	51.92	45.19	24.28	0.75	4.86	1.12	1.12	0.37	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	76.46	2.75	4.86	1.69	0.00	0.21	0.42	0.21	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	109.47	6.58	6.00	1.74	0.58	0.19	5.03	0.39	2.51
gastric cancer cell line:AZ521	10549-107H9	90.67	2.62	10.17	1.48	0.98	0.98	0.00	0.98	1.48
gastric cancer cell line:GSS	10560-108A2	128.13	16.47	12.81	1.83	2.75	2.75	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	129.31	4.34	10.51	1.60	2.97	0.23	0.46	0.46	4.57
giant cell carcinoma cell line:LU65	10487-107B1	107.17	4.13	11.24	2.18	0.34	0.23	0.11	0.69	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	154.93	11.90	9.94	0.98	1.12	1.96	2.66	0.84	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	64.60	5.49	6.24	2.49	0.50	0.25	0.00	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	25.97	3.91	4.86	0.21	0.11	0.53	0.53	0.11	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	22.89	3.93	3.51	0.70	0.42	0.42	0.56	0.14	0.42
glioblastoma cell line:T98G	10485-107A8	77.81	7.62	8.39	0.99	0.99	0.11	0.99	0.88	0.88
glioma cell line:GI-1	10413-106B8	83.76	7.61	7.32	1.76	0.29	0.29	1.46	0.88	1.17
globus pallidus - adult, donor10196	10175-103C4	26.97	5.10	8.02	0.73	1.46	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	101.06	20.26	17.82	3.17	3.91	1.46	0.49	3.66	1.46
globus pallidus, adult, donor10258	10367-105F7	26.01	8.22	19.17	1.37	1.37	1.37	0.00	5.48	1.37
globus pallidus, newborn, donor10223	10364-105F4	51.16	13.86	8.53	1.60	2.13	0.00	2.13	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	63.63	46.50	17.13	0.00	7.34	9.79	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	10.93	0.00	0.00	0.00	0.00	0.00	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	5.23	10.45	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	41.92	5.76	2.24	0.96	0.64	0.32	1.60	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	67.95	7.80	16.99	0.92	0.00	2.75	0.46	0.46	2.75
hIPS +CCl2, biol_rep2	14384-156C1	63.56	6.40	16.00	1.37	0.46	1.37	0.00	0.00	3.20
hIPS +CCl2, biol_rep3	14385-156C2	50.88	8.37	14.17	1.29	0.64	1.29	0.00	0.00	4.51
hIPS, biol_rep1	14380-156B6	40.24	10.06	25.87	0.00	0.00	2.87	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	40.47	6.86	13.72	1.37	0.69	0.69	0.00	0.69	2.74
hIPS, biol_rep3	14382-156B8	30.90	9.93	18.76	0.00	1.10	1.10	0.00	1.10	3.31
hairy cell leukemia cell line:Mo	10712-109I1	106.60	8.91	15.52	2.30	0.86	0.29	1.72	0.57	0.57
heart - mitral valve, adult	10205-103F7	47.24	17.64	15.55	1.79	0.90	2.99	3.29	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	31.38	24.58	14.12	3.40	0.78	3.14	1.05	1.31	0.26
heart - tricuspid valve, adult	10207-103F9	33.31	17.49	13.32	3.33	5.00	1.67	6.66	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	71.42	8.37	10.20	3.67	1.43	2.04	0.61	2.45	0.82
heart, adult, diseased, donor1	10051-101G6	25.12	8.94	10.22	2.13	1.28	1.28	0.85	2.13	0.43
heart, adult, pool1	10016-101C7	19.32	10.12	5.29	0.23	0.46	1.15	0.23	1.61	0.00
heart, fetal, pool1	10046-101G1	54.93	20.74	13.35	0.82	1.95	1.54	0.21	1.13	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	30.85	3.70	2.78	0.62	0.00	0.31	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	21.41	3.57	4.76	1.19	0.00	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	81.44	0.66	10.61	1.55	0.55	0.33	0.99	0.99	2.54
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	82.78	0.73	9.59	1.46	0.61	0.12	0.85	0.73	3.03
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	92.97	0.61	9.20	1.52	1.11	0.10	0.61	1.52	3.23
hepatoma cell line:Li-7	10484-107A7	101.10	3.00	6.01	1.45	1.00	0.33	0.78	0.44	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	61.20	6.33	8.84	0.40	1.31	1.11	0.50	1.41	2.41
hippocampus - adult, donor10196	10169-103B7	41.64	5.68	8.52	7.57	1.89	1.89	0.95	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	65.52	17.96	18.37	3.88	1.22	0.41	0.41	3.67	0.20
hippocampus, adult, donor10258	10374-105G5	28.38	7.97	20.42	1.49	0.50	1.00	1.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	52.52	9.16	13.75	0.00	2.11	1.76	0.35	3.88	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	101.93	12.21	17.70	1.83	1.22	0.00	1.22	0.00	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	67.55	7.07	8.44	2.75	0.79	1.57	1.18	0.39	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	88.36	9.90	15.23	2.79	1.02	2.29	1.27	0.00	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	85.71	20.86	23.12	3.95	1.69	3.38	1.13	1.69	3.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	126.01	18.59	19.62	9.55	2.84	2.07	0.77	0.00	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	86.55	23.54	26.19	2.66	1.14	4.56	1.90	0.38	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	226.26	25.98	18.10	3.21	3.21	2.34	3.21	0.88	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	155.11	19.17	20.25	5.82	2.59	2.15	0.86	0.65	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	187.68	23.77	19.19	4.59	1.67	1.67	1.25	0.83	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	63.70	13.26	14.92	1.66	1.42	1.89	1.66	0.47	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	112.66	15.91	11.57	3.05	1.45	2.73	1.93	1.13	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	43.76	21.55	6.06	2.69	0.67	0.67	2.02	0.00	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	62.91	6.42	10.48	1.72	0.78	1.10	0.47	0.16	5.79
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	87.45	3.93	8.35	3.44	0.49	0.00	0.98	0.98	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	81.17	6.11	13.96	2.62	1.75	2.62	0.87	0.00	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	85.72	23.86	18.71	4.01	0.76	3.82	0.19	1.91	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	75.00	18.32	18.32	1.74	3.05	3.05	0.44	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	110.45	29.49	25.99	4.00	1.50	5.50	0.50	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	80.44	14.13	8.85	3.58	2.64	1.88	1.88	0.94	3.77
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	99.58	10.46	11.37	5.46	5.00	3.18	5.00	0.45	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	80.81	19.73	12.53	3.76	2.82	1.25	1.57	1.25	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	62.22	13.72	11.10	2.78	1.31	1.63	1.31	0.49	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	67.35	9.00	11.61	2.90	1.16	2.03	2.03	0.87	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	84.30	17.34	13.15	2.09	0.60	2.39	0.60	1.20	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	69.65	8.68	13.86	2.59	0.55	1.48	0.74	0.18	4.25
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	60.48	7.99	8.84	0.57	0.29	1.14	0.29	0.57	4.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	100.44	14.29	18.78	2.04	0.41	1.63	2.04	0.41	4.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	99.29	18.31	13.03	3.52	1.41	2.46	0.70	0.35	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	63.03	17.42	12.35	3.80	0.32	2.22	0.95	0.95	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	86.55	22.39	13.32	2.42	1.82	1.82	0.61	0.30	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	95.67	16.03	13.96	3.62	2.59	1.55	1.03	0.52	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	85.68	17.27	18.60	3.32	3.98	1.33	1.33	0.66	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	78.76	17.44	15.14	1.03	1.54	1.03	1.54	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	90.24	12.53	9.97	2.30	1.02	2.05	1.28	0.51	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	88.60	13.63	11.36	0.76	1.51	0.76	0.76	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	69.90	14.79	12.43	1.34	1.01	1.34	0.34	0.67	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	84.29	7.97	12.80	3.86	0.48	1.21	0.97	0.00	4.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	77.54	11.14	18.72	3.57	1.34	3.12	1.34	0.00	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	84.88	13.17	19.02	4.88	0.00	1.95	0.49	0.00	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	83.13	15.28	16.50	4.28	1.53	5.50	0.92	0.61	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	172.42	42.29	48.80	13.01	6.51	3.25	6.51	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	101.27	20.19	25.81	2.98	1.65	2.32	0.33	0.66	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	122.59	21.34	15.87	3.28	1.09	1.64	2.19	0.55	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	93.73	17.37	14.48	5.43	2.53	1.45	1.45	1.45	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	134.88	18.15	19.22	2.49	2.14	2.85	2.85	0.71	3.91
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	91.89	15.51	14.32	5.97	1.19	2.39	3.58	1.19	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	74.21	21.26	13.95	4.33	1.35	2.84	2.71	1.08	1.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	61.42	11.85	10.24	0.81	1.35	1.08	1.08	0.00	0.54
immature langerhans cells, donor1	11904-125F5	151.34	30.27	11.38	2.91	1.94	2.42	1.70	1.21	0.00
immature langerhans cells, donor2	11905-125F6	493.50	17.43	7.92	3.96	0.00	1.58	3.17	3.17	0.00
insula, adult, pool1	10039-101F3	46.84	17.70	26.40	1.32	0.95	2.56	0.76	5.39	1.32
keratoacanthoma cell line:HKA-1	10791-110H8	37.72	8.78	7.15	0.33	0.65	0.98	0.33	0.98	0.00
kidney, adult, pool1	10017-101C8	52.17	12.62	8.61	1.20	0.80	1.40	0.80	1.40	0.40
kidney, fetal, pool1	10045-101F9	85.94	22.14	20.44	0.57	2.48	1.27	2.05	2.26	1.34
large cell lung carcinoma cell line:IA-LM	10509-107D5	86.63	9.52	10.37	0.71	0.85	1.56	0.85	0.85	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	35.11	4.98	4.56	0.69	0.14	0.69	0.69	0.55	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	99.64	5.50	7.52	0.73	1.65	1.10	0.37	0.18	1.47
left atrium, adult, donor1	10079-102A7	13.62	7.63	2.72	0.54	0.54	0.54	0.54	2.72	0.00
left ventricle, adult, donor1	10078-102A6	16.18	4.05	3.54	1.52	0.00	0.00	0.51	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	55.82	6.84	2.46	0.82	0.00	0.82	3.28	0.27	2.19
leiomyoma cell line:10964C	10569-108B2	56.76	3.23	4.31	1.80	0.00	0.00	1.08	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	49.46	1.63	3.26	0.54	0.00	0.00	1.63	0.54	1.09
leiomyoma cell line:15425	10571-108B4	48.08	1.46	4.13	1.46	0.49	0.00	1.46	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	43.91	3.14	7.32	0.00	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	121.13	9.68	5.90	0.83	1.42	3.54	1.65	0.71	2.60
liposarcoma cell line:KMLS-1	10782-110G8	32.18	4.69	3.44	0.94	0.31	0.00	2.34	0.00	0.78
liposarcoma cell line:SW 872	10726-110A6	53.85	6.34	8.04	0.73	0.24	1.22	0.37	0.85	0.61
liver, adult, pool1	10018-101C9	35.33	10.86	7.29	1.46	3.08	0.81	2.11	1.46	1.13
liver, fetal, pool1	10086-102B5	14.11	3.76	7.53	0.00	0.94	0.94	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	29.16	10.50	8.31	1.75	1.17	1.17	0.58	0.87	0.44
locus coeruleus, adult, donor10252	10165-103B3	70.87	12.92	11.44	2.03	0.74	0.92	0.74	3.14	0.92
locus coeruleus, adult, donor10258	10375-105G6	29.62	14.67	14.67	1.97	0.85	1.41	0.56	3.39	0.28
locus coeruleus, newborn, donor10223	10362-105F2	66.88	9.25	10.94	3.79	4.21	0.42	1.68	1.26	1.68
lung adenocarcinoma cell line:A549	10499-107C4	39.86	2.77	2.08	0.42	0.00	0.83	0.28	0.28	1.66
lung adenocarcinoma cell line:PC-14	10408-106B3	28.27	4.14	2.76	0.00	0.00	0.00	0.00	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	109.41	7.78	5.27	2.37	0.40	0.92	1.05	0.79	0.66
lung, adult, pool1	10019-101D1	47.25	23.63	7.56	1.18	1.77	2.36	0.59	2.13	0.83
lung, fetal, donor1	10068-101I5	91.04	41.10	25.69	2.00	10.27	3.71	5.71	2.28	1.14
lung, right lower lobe, adult, donor1	10075-102A3	43.99	27.03	14.20	7.33	2.29	1.83	0.92	5.50	2.29
lymph node, adult, donor1	10077-102A5	28.40	17.51	6.63	1.89	1.42	1.42	0.47	1.89	0.47
lymphangiectasia cell line:DS-1	10727-110A7	67.07	9.42	10.74	1.53	0.66	2.19	0.00	2.19	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	94.63	4.68	8.75	1.21	1.21	0.91	0.45	0.60	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	183.49	9.34	6.80	0.85	2.55	0.85	2.55	0.00	0.85
mature adipocyte, donor1	12231-129F8	185.59	12.88	9.77	1.33	0.89	0.00	0.89	0.89	0.00
mature adipocyte, donor2	12232-129F9	75.54	11.21	7.06	0.21	0.83	0.83	1.87	0.83	0.00
mature adipocyte, donor3	12233-129G1	110.95	9.25	8.77	1.42	0.71	0.95	1.90	0.71	0.00
mature adipocyte, donor4	12234-129G2	121.61	15.27	15.00	1.05	0.00	0.00	2.90	1.84	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	141.29	10.48	14.06	2.38	2.14	1.43	0.71	0.71	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	30.46	4.51	20.30	2.26	0.00	0.00	1.13	3.38	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	63.26	12.14	16.37	2.57	2.21	0.55	0.18	4.41	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	15.57	7.94	20.65	1.27	0.95	1.91	0.00	2.22	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	58.00	8.10	26.44	0.85	1.28	2.13	2.13	1.71	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	44.38	10.80	14.34	5.74	1.69	1.69	0.17	2.19	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	65.79	15.28	18.04	2.33	1.70	1.70	0.42	2.97	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	13.48	26.97	0.00	0.00	1.93	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	28.71	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	83.99	11.13	23.69	0.36	2.51	1.08	1.44	3.95	0.72
medulla oblongata - adult, donor10196	10174-103C3	36.34	11.68	10.38	1.95	0.65	0.65	0.00	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	89.17	18.89	15.17	2.17	2.17	1.24	0.62	3.56	1.39
medulla oblongata, adult, pool1	10038-101F2	36.41	20.57	22.69	0.57	2.45	2.04	0.33	3.67	1.71
medulla oblongata, newborn, donor10223	10361-105F1	42.01	8.68	6.25	1.39	0.69	1.39	1.04	2.08	1.04
medulloblastoma cell line:D283 Med	10838-111E1	272.56	24.58	19.93	8.86	5.09	1.77	0.44	0.00	2.66
medulloblastoma cell line:ONS-76	10759-110E3	35.46	4.65	3.91	0.73	0.24	0.86	0.61	0.24	1.35
melanoma cell line:COLO 679	10514-107E1	117.73	5.32	6.04	1.44	0.43	0.29	1.01	0.72	0.14
melanoma cell line:G-361	10465-106H6	74.92	7.33	7.60	1.36	0.00	0.27	1.36	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	108.00	6.51	5.43	3.26	0.36	0.54	0.72	1.09	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	212.36	17.62	19.39	7.05	0.88	5.29	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	174.46	10.89	22.81	3.37	2.07	2.59	0.26	1.56	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	51.86	3.38	5.06	0.92	0.15	0.15	2.30	0.31	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	62.35	4.00	4.73	0.91	0.55	0.18	2.91	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	36.86	3.73	4.14	0.41	0.83	0.83	2.90	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	35.96	3.37	3.51	0.28	0.14	0.14	0.70	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	31.58	3.47	4.24	0.58	0.58	0.19	0.96	0.58	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	52.06	3.47	3.47	0.00	0.69	0.00	2.08	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	45.65	2.75	3.09	0.51	0.34	0.17	1.03	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	39.34	2.42	4.72	0.23	0.35	0.23	2.07	0.23	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	42.71	2.52	2.79	0.80	0.13	0.13	2.92	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	39.03	2.43	3.65	0.95	0.14	0.27	0.95	0.00	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	44.81	2.56	2.70	0.43	0.00	0.14	1.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	72.13	4.61	4.94	1.32	0.66	0.33	4.28	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	47.05	2.21	3.32	0.83	0.28	0.14	1.25	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	53.06	2.79	5.59	0.70	0.00	0.35	2.79	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	34.71	3.27	2.65	0.41	0.00	0.61	0.41	0.61	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	65.06	5.75	3.95	0.36	0.36	0.36	1.44	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	32.59	3.21	3.21	0.31	0.21	0.00	1.14	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	45.14	1.60	2.28	0.46	0.00	0.00	0.46	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	58.32	1.68	1.26	0.00	0.00	0.42	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	44.83	4.48	3.14	1.05	0.15	0.30	0.90	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	63.81	2.19	2.36	0.53	0.09	0.26	1.84	0.35	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	46.76	5.15	3.68	0.74	0.37	0.74	2.95	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	55.23	3.72	2.86	0.86	0.57	0.57	3.43	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	71.99	6.32	6.74	2.53	0.00	0.00	0.42	0.84	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	34.71	4.11	6.39	0.00	0.00	0.00	1.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	37.09	4.86	6.39	1.02	0.51	0.00	1.02	0.51	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	44.76	6.02	7.33	0.26	0.26	0.26	4.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	37.59	6.16	5.85	0.62	0.00	0.31	3.39	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	35.54	5.18	2.35	1.18	0.00	0.00	1.65	0.00	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	30.80	4.40	6.77	0.34	0.00	0.00	3.38	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	34.97	3.54	6.29	0.39	0.39	1.18	2.36	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	34.75	5.56	7.88	0.00	0.00	0.46	1.39	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	44.13	4.33	4.61	0.29	0.29	0.58	1.44	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	36.81	5.13	4.91	0.67	0.00	0.22	0.67	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	45.67	4.09	5.05	0.72	0.00	0.96	0.96	0.72	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	33.00	3.67	4.40	0.73	0.00	0.00	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	38.26	4.36	7.38	0.00	0.34	0.34	2.35	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	29.48	6.14	7.37	0.00	0.00	1.23	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	40.38	7.30	9.45	0.43	0.43	0.86	1.72	0.43	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	5.47	5.47	0.00	2.73	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	5.16	10.33	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	34.10	7.15	5.85	0.32	0.00	0.97	1.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	34.92	2.91	2.91	2.91	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.12	6.40	4.26	1.60	0.53	0.53	2.67	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.17	3.27	7.36	1.64	0.00	0.00	1.64	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	33.82	4.66	4.28	0.78	0.00	0.00	0.78	1.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	4.20	2.10	2.10	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	30.80	5.96	8.94	1.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	0.00	9.53	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	34.98	7.71	7.71	1.19	0.00	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	34.12	4.87	4.87	0.00	0.00	0.00	3.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	27.24	5.70	4.43	0.63	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	39.32	6.90	3.79	1.03	1.03	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	45.13	6.45	2.15	0.00	2.15	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	3.44	6.89	6.89	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	27.30	4.48	9.37	0.81	0.00	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	25.42	10.33	3.18	0.79	0.00	0.79	1.59	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	24.17	4.13	2.36	0.00	0.00	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	27.12	5.61	2.18	0.00	0.94	0.31	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	9.36	5.35	2.67	1.34	0.00	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	2.37	4.73	1.18	0.00	0.00	4.73	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	41.09	0.00	2.57	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	30.29	6.20	6.20	0.69	0.00	0.00	4.82	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	55.91	5.94	4.45	0.00	0.49	0.49	2.47	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	52.71	3.36	5.61	1.12	0.00	0.00	1.12	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	62.97	2.54	3.82	1.91	1.27	1.27	1.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	54.40	5.24	5.24	1.61	1.21	0.40	2.01	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	45.79	4.36	15.26	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	49.42	7.60	2.53	2.53	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	46.12	7.89	9.10	0.61	3.03	0.61	1.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	0.00	9.04	13.56	4.52	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	37.89	8.24	4.94	1.65	0.82	0.00	1.65	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	18.85	6.75	5.36	0.20	0.60	0.60	2.18	0.00	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	28.23	5.19	3.57	0.32	0.65	0.97	1.95	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	24.45	5.09	4.07	0.00	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.99	5.42	1.55	0.00	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	70.16	6.61	3.54	0.47	0.24	0.71	0.71	0.47	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	106.34	4.40	3.48	1.39	0.00	0.70	2.55	0.00	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	51.28	4.27	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	26.41	3.90	5.45	0.31	0.62	0.51	2.36	0.21	1.03
mesothelioma cell line:Mero-25	10850-111F4	152.06	2.95	4.09	1.82	0.68	0.23	4.31	0.23	3.86
mesothelioma cell line:Mero-41	10851-111F5	74.32	4.40	4.89	0.73	0.00	0.24	2.93	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	57.35	4.43	5.54	0.89	0.22	1.11	1.55	0.22	0.66
mesothelioma cell line:Mero-82	10853-111F7	100.13	4.73	6.31	2.89	1.31	1.31	3.42	0.53	1.84
mesothelioma cell line:Mero-83	10854-111F8	79.66	4.26	6.98	1.87	0.00	0.34	1.87	0.17	1.70
mesothelioma cell line:Mero-84	10855-111F9	49.54	4.55	5.06	0.51	0.00	0.51	0.51	0.00	1.26
mesothelioma cell line:Mero-95	10856-111G1	37.68	6.42	5.80	0.83	0.21	0.62	1.24	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	44.72	1.66	4.31	0.50	0.17	0.17	0.50	0.00	0.50
mesothelioma cell line:NCI-H226	10846-111E9	48.14	2.71	2.35	1.09	0.54	0.18	3.62	0.00	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	39.97	5.64	11.96	0.85	0.85	0.51	0.34	0.34	1.37
mesothelioma cell line:NCI-H28	10845-111E8	60.82	3.56	10.94	0.76	1.27	0.51	0.51	0.00	3.05
mesothelioma cell line:No36	10857-111G2	17.94	4.24	5.22	0.65	0.33	0.00	2.28	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	117.05	9.48	13.01	1.08	0.27	1.08	2.44	0.00	0.54
migratory langerhans cells, donor1	11901-125F2	68.32	9.21	7.29	2.69	0.00	0.38	0.38	1.54	0.58
migratory langerhans cells, donor2	11902-125F3	60.33	17.95	7.94	0.24	0.37	2.20	0.61	1.10	0.37
migratory langerhans cells, donor3	11903-125F4	44.87	14.72	8.08	0.18	0.00	2.15	1.26	1.26	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	138.10	13.06	5.22	6.20	0.65	0.33	2.61	0.65	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	75.24	3.81	3.60	2.12	0.64	0.64	0.64	0.21	1.91
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	55.98	13.36	4.61	0.69	0.23	1.38	0.00	0.46	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	78.59	8.37	5.14	1.71	0.76	0.19	1.14	1.33	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	57.84	4.80	10.16	0.92	0.92	0.37	0.37	0.74	0.74
myeloma cell line:PCM6	10474-106I6	61.47	9.29	3.95	0.99	2.57	0.59	0.00	4.55	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	43.63	2.54	2.03	0.51	0.00	0.51	1.52	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	92.19	5.49	8.24	0.20	0.78	0.20	2.55	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	44.46	9.58	5.46	1.11	0.78	0.33	0.45	0.78	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	42.87	7.94	5.00	0.37	1.10	0.59	0.29	0.66	1.40
nasal epithelial cells, donor2	12227-129F4	85.01	13.25	5.52	0.55	0.55	0.55	0.55	0.00	2.21
neuroblastoma cell line:CHP-134	10508-107D4	69.02	17.02	17.25	1.38	2.76	2.53	0.46	0.69	2.76
neuroblastoma cell line:NB-1	10539-107G8	70.16	11.97	10.66	0.37	1.68	0.94	0.75	1.31	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	155.00	5.27	13.29	1.69	2.11	1.69	0.21	1.27	0.84
neuroblastoma cell line:NH-12	10555-107I6	160.82	15.84	20.68	2.42	3.91	1.12	0.19	0.56	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	100.82	4.51	22.54	3.56	5.93	2.61	0.00	4.03	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	110.87	11.40	12.67	2.53	5.23	2.85	0.95	3.01	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	59.57	6.64	9.86	0.60	1.21	1.01	0.40	1.41	5.43
neuroepithelioma cell line:SK-N-MC	10728-110A8	38.78	4.45	14.62	1.27	2.54	3.18	0.00	2.54	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	25.55	3.99	2.13	0.53	0.53	0.53	1.60	0.53	0.00
neutrophil PMN, donor1	12133-128D9	0.00	505.74	0.00	0.00	0.00	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	132.59	28.41	0.00	0.00	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	160.33	25.54	20.97	1.01	8.96	4.57	0.51	3.04	2.20
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	16.81	9.61	5.60	0.00	0.80	1.60	0.00	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	49.69	3.21	5.13	1.28	0.00	0.00	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	54.66	8.15	3.68	0.79	0.00	0.26	1.58	0.53	1.05
nucleus accumbens, adult, pool1	10037-101F1	41.34	13.69	22.31	0.94	0.84	1.87	0.37	4.41	1.78
occipital cortex - adult, donor10196	10172-103C1	32.97	4.12	16.48	4.12	2.06	2.06	0.00	2.06	4.12
occipital cortex, adult, donor10252	10163-103B1	69.51	20.13	22.27	4.56	1.61	1.07	1.07	4.83	2.68
occipital cortex, newborn, donor10223	10355-105E4	89.17	11.28	21.84	1.82	1.46	1.82	1.09	5.82	0.73
occipital lobe, adult, donor1	10076-102A4	33.06	6.56	11.55	2.10	0.79	1.57	0.26	4.99	0.26
occipital lobe, fetal, donor1	10073-102A1	58.79	18.02	12.01	5.15	3.86	4.72	0.00	12.87	2.15
occipital pole, adult, pool1	10036-101E9	29.33	13.09	26.96	0.47	1.10	2.05	0.39	3.78	1.26
olfactory region, adult	10195-103E6	30.00	10.89	14.33	1.72	0.96	0.76	0.57	3.06	1.15
optic nerve, donor1	10277-104E7	18.01	24.01	8.00	2.00	4.00	0.00	0.00	2.00	8.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	87.48	7.18	8.54	0.80	0.34	0.57	0.34	0.80	1.48
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	60.18	5.36	5.63	1.37	0.41	0.96	0.14	0.14	1.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	100.92	11.18	8.30	2.54	0.68	2.71	1.02	0.51	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	145.77	10.16	8.20	1.96	0.35	0.81	0.58	1.50	1.04
osteoclastoma cell line:Hs 706.T	10704-109H2	52.33	6.76	5.88	0.00	0.59	0.29	1.47	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	54.19	16.82	2.80	0.00	0.00	0.93	0.93	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	108.15	16.33	8.27	1.91	3.82	3.18	3.39	0.64	3.61
ovary, adult, pool1	10020-101D2	49.88	17.03	11.88	0.52	3.67	1.75	1.92	2.88	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	52.80	5.87	2.93	0.18	0.00	1.10	0.00	0.37	0.73
pancreas, adult, donor1	10049-101G4	70.55	20.69	12.23	5.64	0.94	2.82	0.94	3.76	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	54.79	10.06	9.50	1.40	0.28	2.24	0.00	1.68	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	93.01	2.90	7.50	2.56	0.17	0.17	1.02	0.34	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	61.10	2.98	7.62	0.83	0.33	0.17	0.33	0.50	0.50
paracentral gyrus, adult, pool1	10035-101E8	33.31	13.55	26.82	1.10	0.73	1.65	0.27	3.57	1.28
parietal cortex, adult, donor10258	10373-105G4	54.32	11.01	20.55	0.73	0.00	1.47	0.00	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	7.52	17.87	0.00	1.88	0.94	0.00	3.76	0.94
parietal lobe, adult, donor10252	10157-103A4	64.13	14.54	17.39	2.00	0.86	0.86	0.57	2.85	0.29
parietal lobe, adult, pool1	10034-101E7	32.08	11.98	21.06	0.88	1.06	1.85	0.18	4.49	1.67
parietal lobe, fetal, donor1	10072-101I9	43.64	15.52	22.31	2.91	5.82	5.82	0.97	7.76	2.91
parietal lobe, newborn, donor10223	10356-105E5	76.64	9.72	25.05	2.99	1.12	2.24	3.36	2.62	0.75
parotid gland, adult	10199-103F1	61.05	17.88	28.37	1.23	3.70	3.08	1.23	1.23	1.23
penis, adult	10200-103F2	45.65	31.69	17.72	2.69	4.83	1.61	3.22	1.61	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	77.91	14.50	9.67	2.23	3.35	1.12	0.56	1.67	5.76
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	56.53	8.01	4.37	0.73	0.73	1.31	0.15	0.73	0.73
pineal gland - adult, donor10196	10179-103C8	36.77	7.74	18.06	2.58	0.65	1.94	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	55.67	26.65	24.87	1.78	1.18	1.18	0.00	2.96	0.00
pineal gland, adult, donor10258	10377-105G8	33.86	15.05	15.68	1.88	1.88	2.51	0.00	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	71.84	8.09	20.24	2.02	0.00	1.01	0.00	2.02	2.02
pituitary gland, adult, donor10252	10162-103A9	108.93	20.33	40.13	2.61	1.56	2.61	0.52	7.82	1.04
pituitary gland, adult, donor10258	10378-105G9	60.44	25.54	36.60	4.26	0.85	4.26	0.85	4.26	0.85
placenta, adult, pool1	10021-101D3	40.96	15.37	15.91	0.65	1.51	1.51	0.54	1.94	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	202.35	6.62	13.24	2.91	2.25	1.99	0.40	1.59	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	54.94	13.85	5.29	0.78	0.78	0.47	0.16	0.47	0.16
pons, adult, pool1	10033-101E6	32.88	12.14	17.64	0.77	1.46	2.07	0.86	2.58	0.95
postcentral gyrus, adult, pool1	10032-101E5	35.39	12.73	25.89	0.52	0.96	1.83	0.35	4.79	1.66
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	69.02	10.46	0.00	2.09	18.82	2.09	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	5.51	0.00	0.00	0.00	0.00	0.00	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	23.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	84.19	11.36	8.59	2.33	0.29	1.02	1.02	0.87	1.75
prostate cancer cell line:PC-3	10439-106E7	61.71	4.90	3.81	1.63	0.36	0.73	1.45	0.18	0.00
prostate, adult, pool1	10022-101D4	42.63	30.02	13.24	0.45	1.27	2.00	1.09	1.18	0.54
putamen, adult, donor10196	10176-103C5	55.47	7.55	13.22	1.89	0.47	0.71	0.24	2.83	1.42
putamen, adult, donor10252	10152-102I8	21.57	13.73	27.45	3.92	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	15.30	3.28	12.02	1.09	2.19	0.00	1.09	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	27.79	5.80	18.36	0.97	0.97	0.72	0.48	0.97	0.72
putamen, newborn, donor10223	10365-105F5	66.72	3.75	20.24	2.25	2.25	0.00	1.50	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	103.28	4.36	7.56	1.16	0.29	0.58	0.58	0.00	0.29
rectum, fetal, donor1	10067-101I4	31.99	37.56	13.91	1.39	2.78	1.39	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	56.18	2.97	3.39	1.27	0.42	0.64	0.42	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	82.84	4.97	1.24	2.90	2.49	0.41	2.07	0.41	0.41
retina, adult, pool1	10030-101E3	57.65	29.52	19.98	1.19	2.58	3.68	0.80	2.09	1.29
retinoblastoma cell line:Y79	10475-106I7	147.57	17.67	18.19	2.60	2.60	2.60	0.52	1.56	8.05
rhabdomyosarcoma cell line:KYM-1	10787-110H4	87.79	4.43	5.29	1.11	0.25	0.25	1.48	0.37	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	101.23	12.94	11.81	1.12	3.09	2.81	0.00	0.56	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	68.96	4.55	3.79	0.00	0.00	0.76	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	43.38	9.06	5.34	0.81	0.16	0.97	0.97	0.16	1.46
salivary acinar cells, donor2	11772-123I8	40.76	9.78	7.71	1.51	1.93	0.83	0.28	0.41	0.41
salivary acinar cells, donor3	11773-123I9	17.88	17.21	7.28	0.66	0.66	1.32	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	56.62	28.03	23.45	1.14	0.57	1.72	1.14	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	65.26	6.58	8.26	1.18	0.42	0.76	1.01	0.08	1.77
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	59.95	4.47	8.35	1.18	0.59	0.71	1.18	0.47	1.88
seminal vesicle, adult	10201-103F3	84.65	20.63	15.87	10.05	0.53	1.59	1.06	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	114.66	9.23	9.72	2.19	0.00	0.49	3.16	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	172.62	2.77	3.52	3.02	0.00	0.50	0.75	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	105.37	3.01	12.04	2.01	0.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	95.10	18.27	9.40	1.48	0.81	2.82	0.40	0.67	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	105.89	6.30	7.52	0.55	1.66	0.99	0.44	1.11	1.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	64.77	4.77	5.42	0.90	0.00	0.77	0.52	0.52	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	14.90	6.38	6.38	2.13	0.00	0.00	0.71	0.00	2.84
skeletal muscle, adult, pool1	10023-101D5	31.42	21.83	10.55	0.36	1.32	0.96	0.12	1.56	1.08
skeletal muscle, fetal, donor1	10066-101I3	19.10	16.08	5.03	2.01	1.01	1.01	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	13.57	20.36	20.36	0.00	0.00	6.79	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	41.66	14.52	8.21	3.16	1.89	0.63	0.63	1.89	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	146.08	10.34	10.01	1.33	0.33	0.67	1.00	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	180.93	7.25	34.04	5.67	6.93	1.26	0.32	3.47	2.84
small cell lung carcinoma cell line:DMS 144	10841-111E4	182.15	4.63	17.54	3.85	1.16	2.31	1.54	1.16	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	136.15	11.21	12.36	0.66	0.82	0.82	0.33	1.48	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	238.70	7.72	20.91	4.50	5.47	0.48	0.00	0.64	2.41
small cell lung carcinoma cell line:WA-hT	10562-108A4	126.39	13.29	18.96	1.96	1.96	1.96	0.87	3.49	2.40
small intestine, adult, pool1	10024-101D6	37.62	15.17	17.08	0.96	1.67	1.91	2.87	2.63	0.36
small intestine, fetal, donor1	10064-101I1	40.54	9.34	13.02	3.44	1.97	0.49	6.39	2.46	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	131.30	8.21	15.39	5.13	2.56	1.54	0.51	1.54	0.51
smooth muscle, adult, pool1	10048-101G3	29.46	29.98	6.72	1.55	1.29	2.33	1.55	1.03	1.29
somatostatinoma cell line:QGP-1	10781-110G7	49.85	8.84	6.16	0.27	0.27	1.61	0.00	1.34	0.54
spinal cord - adult, donor10196	10181-103D1	37.85	12.16	11.24	2.06	2.06	1.61	0.46	1.61	1.15
spinal cord, adult, donor10252	10159-103A6	70.57	20.90	17.35	1.18	1.18	1.97	0.39	3.55	1.58
spinal cord, adult, donor10258	10369-105F9	47.04	6.92	14.53	4.84	0.69	1.38	0.69	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	39.64	15.86	14.64	1.22	2.44	2.44	1.83	4.27	1.22
spinal cord, newborn, donor10223	10359-105E8	38.57	10.56	15.15	2.30	2.76	2.30	1.84	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	40.18	4.03	2.09	0.90	0.15	0.15	1.49	0.45	0.00
spleen, adult, pool1	10025-101D7	37.45	16.52	17.51	1.32	1.32	2.86	0.55	3.85	0.22
spleen, fetal, pool1	10044-101F8	64.04	27.57	18.83	0.95	5.32	4.29	1.19	3.26	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	54.97	6.00	9.73	0.72	0.52	0.52	0.83	0.72	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	79.56	9.30	1.90	1.33	0.19	0.95	0.76	0.38	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	153.06	8.39	14.33	4.89	0.00	0.70	1.05	1.75	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	106.72	7.04	7.43	1.17	0.39	0.78	3.52	0.00	2.74
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	126.97	5.74	10.47	2.03	0.45	0.23	1.13	0.79	1.46
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	108.02	7.20	7.62	1.69	2.12	1.69	0.00	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	130.73	9.73	6.77	1.69	0.00	0.42	0.42	0.85	0.00
stomach, fetal, donor1	10062-101H8	21.36	41.65	12.82	1.07	1.07	2.14	0.00	1.07	1.07
submaxillary gland, adult	10202-103F4	84.31	19.37	19.37	1.71	1.71	2.28	1.14	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	95.75	17.03	13.29	2.70	2.49	1.25	0.00	1.87	1.04
substantia nigra, adult, donor10258	10371-105G2	23.79	8.28	12.41	3.62	0.52	1.55	0.52	0.52	1.55
substantia nigra, newborn, donor10223	10358-105E7	36.04	11.31	7.77	2.12	1.41	2.12	0.71	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	61.21	5.27	9.63	0.46	0.92	3.21	0.69	1.15	1.38
temporal lobe, adult, pool1	10031-101E4	39.84	14.07	25.26	2.03	1.02	1.53	0.42	4.07	1.61
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	67.67	10.68	19.94	4.99	1.42	2.14	0.71	6.41	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	99.78	11.43	28.13	3.08	0.88	2.64	0.44	0.88	0.44
tenocyte, donor1	11763-123H8	50.97	5.59	10.47	3.14	0.35	0.00	2.44	0.00	0.00
tenocyte, donor2	11765-123I1	51.88	6.87	12.59	1.14	1.14	0.76	0.76	0.38	0.76
tenocyte, donor3	11768-123I4	58.57	4.45	8.15	1.48	0.74	0.74	0.37	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	55.41	5.10	5.27	0.51	0.68	1.02	0.34	1.53	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	49.48	11.87	6.47	0.92	1.70	1.85	1.08	0.31	2.16
teratocarcinoma cell line:PA-1	10807-111A6	70.05	6.97	5.42	1.24	0.77	0.93	0.00	0.77	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	62.97	8.38	6.09	1.52	1.02	2.67	1.14	1.27	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	78.28	14.37	16.64	1.89	1.51	0.76	0.00	3.03	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	71.00	26.72	9.71	1.31	2.40	1.96	1.20	4.47	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	130.93	10.10	6.51	1.30	1.63	0.65	0.65	0.33	0.00
testis, adult, pool1	10026-101D8	88.58	13.31	13.53	4.29	2.90	0.97	0.64	8.05	0.64
testis, adult, pool2	10096-102C6	189.46	10.83	27.52	9.47	3.61	0.00	0.00	7.67	1.35
thalamus - adult, donor10196	10168-103B6	59.62	3.31	7.73	2.21	0.00	1.10	0.00	2.21	1.10
thalamus, adult, donor10252	10154-103A1	94.24	17.03	16.25	2.03	1.72	1.41	1.09	4.38	1.72
thalamus, adult, donor10258, tech_rep1	10370-105G1	33.87	9.24	23.09	3.08	1.54	4.62	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	23.39	11.53	11.20	1.81	1.32	0.66	0.49	2.96	0.82
thalamus, newborn, donor10223	10366-105F6	59.83	5.18	10.93	3.45	2.30	0.00	1.15	1.15	0.00
throat, adult	10209-103G2	42.69	21.72	13.98	1.00	3.50	0.50	1.25	1.75	1.75
throat, fetal, donor1	10061-101H7	33.52	19.20	13.10	2.44	3.35	3.35	1.22	1.52	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	200.12	12.92	12.92	3.38	2.78	2.98	0.40	1.99	1.39
thymus, adult, pool1	10027-101D9	84.30	11.93	13.02	1.69	5.67	7.36	0.50	2.39	1.69
thymus, fetal, pool1	10043-101F7	123.23	23.07	21.82	1.45	11.12	10.49	0.62	3.74	3.53
thyroid carcinoma cell line:KHM-5M	10776-110G2	83.63	9.97	7.71	1.60	1.06	0.13	1.86	0.53	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	72.22	14.67	9.50	1.40	1.40	1.54	1.96	1.40	2.37
thyroid, adult, pool1	10028-101E1	69.98	24.91	16.52	1.31	2.15	2.05	1.49	2.99	0.84
thyroid, fetal, donor1	10060-101H6	57.74	26.37	25.05	6.59	2.64	3.95	1.32	3.16	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	15.40	15.40	0.00	6.16	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	49.31	9.77	6.28	3.02	1.16	1.63	0.93	1.16	0.93
tongue, fetal, donor1	10059-101H5	33.10	13.01	7.49	1.58	1.58	1.97	0.39	0.79	0.00
tonsil, adult, pool1	10047-101G2	67.42	26.25	22.94	0.80	3.51	3.91	0.50	2.20	1.20
trachea, adult, pool1	10029-101E2	54.97	17.83	11.21	0.98	0.98	1.55	1.96	0.98	0.41
trachea, fetal, donor1	10058-101H4	38.85	19.62	13.08	0.77	2.69	2.69	3.08	1.54	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	35.78	2.48	3.54	0.00	0.00	0.00	1.42	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	78.52	4.15	5.78	0.81	0.61	0.61	0.20	0.30	1.52
transitional-cell carcinoma cell line:JMSU1	10492-107B6	106.39	19.59	15.98	3.29	1.41	1.25	1.88	0.31	5.17
tridermal teratoma cell line:HGRT	10694-109G1	30.44	3.81	1.90	0.00	0.00	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	48.17	6.77	8.80	1.02	1.27	0.25	1.35	0.68	1.52
umbilical cord, fetal, donor1	10057-101H3	35.47	6.26	6.26	2.09	2.09	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	49.48	46.75	22.01	0.51	2.73	2.56	3.75	2.22	0.68
uterus, fetal, donor1	10055-101H1	30.20	18.43	9.73	3.07	1.54	2.05	2.56	0.00	1.02
vagina, adult	10204-103F6	47.17	31.66	10.99	0.65	3.23	0.00	1.29	3.88	0.00
vein, adult	10191-103E2	61.16	15.78	14.69	2.41	2.63	3.51	1.75	1.75	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	70.23	6.41	7.48	0.80	0.53	1.60	0.80	0.27	0.80